etoposide has been researched along with Diffuse Large B-Cell Lymphoma in 407 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (0.98) | 18.7374 |
| 1990's | 62 (15.23) | 18.2507 |
| 2000's | 110 (27.03) | 29.6817 |
| 2010's | 154 (37.84) | 24.3611 |
| 2020's | 77 (18.92) | 2.80 |
| Authors | Studies |
|---|---|
| Attarbaschi, A; Burkhardt, B; Ebinger, M; Garthe, AK; Kabíčková, E; Klapper, W; Knörr, F; Kühnle, I; Maecker-Kolhoff, B; Oschlies, I; Ruf, S; Simonitsch-Klupp, I; Woessmann, W; Zimmermann, M | 1 |
| Adamson, PC; Alexander, S; Aupérin, A; Barkauskas, DA; Bollard, CM; Burke, GAA; Chiang, AK; Csoka, M; Dartigues, P; Delgado, R; Gross, TG; Haouy, S; Kazanowska, B; Miles, RR; Minard-Colin, V; Patte, C; Pillon, M; Uyttebroeck, A; Vassal, G; Wheatley, K; Zsíros, J | 1 |
| Brown, JR; Davids, MS; Fisher, DC; Ihuoma, U; Jacobson, CA; Lehmberg, TZ; Montegaard, J; Parry, EM; Pazienza, S; Renner, SK; Rogers, KA; Thompson, PA; Tyekucheva, S; Wang, Z; Wu, CJ | 1 |
| Major, A; Smith, SM | 1 |
| Aumann, S; Gatt, ME; Goldschmidt, N; Horowitz, NA; Morgenstern, Y; Nachmias, B | 1 |
| Angelopoulou, MK; Arapaki, M; Chatzidimitriou, C; Liaskas, A; Plata, E; Rondogianni, P; Tsirigotis, P; Vassilakopoulos, TP | 1 |
| Abgral, R; Berthou, C; Guillerm, G; Ianotto, JC; LE Roux, PY; Lombion, N; Robin, P; Salaün, PY; Schick, U; Tempescul, A | 1 |
| Dong, T; Jing, F; Song, W; Wang, L; Wang, Y; Xiao, S; Xue, H | 1 |
| Auperin, A; Bosq, J; Couec, ML; Dartigues, P; Dourthe, ME; Ducassou, S; Garnier, N; Haouy, S; Leblanc, T; Leruste, A; Minard-Colin, V; Paillard, C; Patte, C; Phulpin, A; Rigaud, C; Simonin, M | 1 |
| Cheng, P; Diakun, D; McMorrow, D; Snider, JT; Song, X; Wade, SW | 1 |
| Assane, C; Malo, FC; Mansouri, S | 1 |
| Kennedy, G; Morris, K; Nelles, R; Scott, A | 1 |
| Borawska, A; Chełstowska, M; Dąbrowska-Iwanicka, A; Domańska-Czyż, K; Druzd-Sitek, A; Giebel, S; Knopińska-Posłuszny, W; Konecki, R; Kumiega, B; Lange, A; Malenda, A; Michalski, W; Mordak-Domagała, M; Najda, J; Osowiecki, M; Ostrowska, B; Paszkiewicz-Kozik, E; Pluta, A; Popławska, L; Romejko-Jarosińska, J; Rymkiewicz, G; Świerkowska, M; Szpila, T; Szymański, M; Targoński, Ł; Taszner, M; Walewski, J; Zaucha, JM | 1 |
| Lakhotia, R; Melani, C; Roschewski, M; Wilson, WH | 1 |
| Agreda-Vásquez, GP; Avendano, O; Barreyro, P; Cubero, D; Enrico, A; Fogliatto, L; Machnicki, G; Mela-Osorio, MJ; Ovilla, R; Pavlovsky, M; San Sebastián, JA; Trufelli, D; Villanova, P | 1 |
| He, ZY; Jin, J; Mai, WY; Mao, LP; Meng, HT; Suo, SS; Wang, JH; Wei, JY; Yang, M; Yu, WJ | 1 |
| Agrawal, A; Bagal, B; Bonda, VNA; Epari, S; Goda, JS; Gujral, S; Jain, H; Jobanputra, K; Khanna, N; Laskar, S; Nayak, L; Rangarajan, V; Sengar, M; Shet, T; Thorat, J | 1 |
| Abdulhaq, H; Baweja, A; Brem, EA; Daniel, CE; Gaut, D; Lee, M; Ly, J; Oliai, C; Othman, T; Penaloza, J; Pinter-Brown, L; Reid, J; Tuscano, J; Zhang, S | 1 |
| Wang, W; Wei, C; Yang, S; Zhan, J; Zhang, W; Zhang, Y; Zhou, D | 1 |
| Kusec, R; Lucijanic, M; Pejsa, V; Sabljic, A; Sedinic Lacko, M | 1 |
| Cerdeña, S; Cortese, MJ; Grover, NS; Haverkos, B; Hill, BT; Hughes, ME; Jodon, G; Kahl, BS; Kaiser, J; Kamdar, M; Landsburg, DJ; Namoglu, E; Olson, M; Orellana-Noia, V; Portell, C; Rainey, M; Rudoni, J; Snow, A; Sohail, M; Voorhees, T; Watkins, MP; Wei, W | 1 |
| Agarwal, A; Alahari, A; Bagal, B; Gota, V; Gujral, S; Gupta, H; Jain, H; Kannan, S; Kumar, S; Laskar, SS; Menon, H; Nayak, L; Rangarajan, V; Sengar, M; Sharma, N; Shet, T; Sridhar, E; Thorat, J | 1 |
| Anampa-Guzmán, A; Block, A; Darrall, A; DeMarco, J; Ghione, P; Groman, A; Hernandez-Ilizaliturri, FJ; Hutson, A; Johnson, M; Kader, A; Kostrewa, J; Lund, I; Mavis, C; McWhite, K; Mohr, A; Nichols, J; Przespolewski, E; Sait, SJ; Sundaram, S; Thomas, R; Torka, P; Wong, J | 1 |
| Cheng, Q; Hou, M; Li, L; Li, T; Yu, J; Zha, S; Zheng, Q | 1 |
| Alizadeh, AA; Chabon, JJ; Gooley, T; Gopal, AK; Hogan, GJ; Keo, S; Kurtz, DM; Lee, S; Lynch, RC; Morris, K; Ottemiller, S; Poh, C; Rasmussen, H; Schulz, A; Shadman, M; Shelby, M; Smith, SD; Ujjani, CS; Verni, K; Voutsinas, JM; Warren, EH | 1 |
| Beishuizen, A; Bhojwani, D; Burke, GAA; Burkhardt, B; Cairo, M; Curtis, M; Deshpande, S; Howes, A; Kabickova, E; Kang, HJ; Luisi, F; Minard-Colin, V; Norris, R; Nottage, K; Srinivasan, S; Sun, S; Tacyildiz, N; Tamegnon, M; Uyttebroeck, A; Vinti, L | 1 |
| Liang, Y; Liu, X; Piao, Y; Wang, H; Wang, L; Wei, L; Yang, J | 1 |
| Arai, A; Asano, N; Fukuhara, N; Hasegawa, Y; Iwaki, N; Izutsu, K; Katayama, N; Kato, K; Kinoshita, T; Masaki, Y; Matsumoto, K; Miyawaki, K; Miyazaki, K; Munemoto, S; Murayama, K; Nishikori, M; Nishimura, Y; Ohshima, K; Okamoto, A; Sakai, R; Sawazaki, A; Suehiro, Y; Sunami, K; Suzuki, R; Takahashi, N; Tamaru, S; Toyama, K; Tsunemine, H; Wake, A; Yamada, T; Yamaguchi, M; Yamamoto, G; Yano, H; Yokoyama, A; Yoshida, I | 1 |
| Aurer, I; Dreta, B; Dujmovic, D; Gacina, P; Galusic, D; Holik, H; Jaksic, O; Kinda, SB; Mitrovic, Z; Pejsa, V; Perisa, V; Prka, Z | 1 |
| Iino, H; Kanaya, S; Matsumura, I; Nakayama, K; Noguchi, H; Saito, A; Tahara, K; Terasaki, S; Toyama, K; Yoshida, T | 1 |
| Angelopoulou, MK; Arapaki, M; Belia, M; Drandakis, I; Korkolopoulou, P; Lakiotaki, E; Panitsas, F; Plata, E; Siakantaris, MP; Triantafyllou, EF; Vassilakopoulos, TP | 1 |
| Acar, R; Albayrak, M; Aykan, MB; Aylı, M; Barısta, I; Dogan, A; Ekıncı, O; Elıbol, T; Erdogan, I; Erturk, I; Esen, R; Gokmen, A; Guven, DC; Kaptan, K; Karadurmus, N; Keskın, GY; Kılıçarslan, E; Kızıloz, H; Paydaş, S; Sahın, U; Sayın, S; Soydan, E; Tıglıoglu, M; Yıldırım, M; Yıldız, B | 1 |
| Ansari-Lari, MA; Ayers, EC; Beckman, AK; Bock, AM; Bond, DA; Chang, JE; Chaudhry, A; Epperla, N; Evens, AM; Farooq, U; Girton, M; Haverkos, B; Hu, M; Hughes, ME; Kamdar, M; Karimi, YH; Karmali, R; Kothari, SK; Kress, A; Kurt, H; Landsburg, DJ; Li, S; Medeiros, LJ; Naik, SG; Naresh, KN; Nowakowski, GS; Nutsch, H; Oh, TS; Olszewski, AJ; Pandya, K; Rubinstein, PG; Saad, M; Sandoval-Sus, J; Smith, SD; Stepanovic, A; Sundaram, S; Torka, P; Vose, JM; Xu, ML; Zayac, AS | 1 |
| Bai, B; Gao, Y; He, Y; Huang, C; Huang, H; Ping, L; Shi, L; Wang, X | 1 |
| Burke, SM; Ghasemi, M; Goey, AKL; Hernandez-Ilizaliturri, FJ; Lin, LH; Mager, DE; Mavis, CK; Nichols, JR; Torka, P | 1 |
| Boonlerd, P; Chai-Adisaksopha, C; Hantrakool, S; Hantrakun, N; Norasetthada, L; Piriyakhuntorn, P; Punnachet, T; Rattanathammethee, T; Rattarittamrong, E; Tantiworawit, A | 1 |
| Aritaka, N; Fukuda, Y; Hamano, Y; Hirano, T; Iizuka, H; Inano, T; Izumi, H; Morita, K; Nakamura, N; Noguchi, M; Okamura, T; Okubo, M; Sakajiri, S; Sato, E; Sawada, T; Sekiguchi, Y; Sugimoto, K; Takizawa, H; Tomita, S; Wakabayashi, M; Yahata, Y | 1 |
| Bartlett, NL; Leonard, JP; Wilson, WH | 1 |
| Brown, AM; Marini, BL; Nachar, VR; Perissinotti, AJ; Phillips, TJ; Weis, TM | 1 |
| Chełstowska, M; Długosz-Danecka, M; Giza, A; Jurczak, W; Końska, A; Kołkowska-Leśniak, A; Lech-Marańda, E; Malenda, A; Puła, B; Warzocha, K | 1 |
| Chuang, HH; Goswamy, R; Lee, HJ; Miranda, RN; Navsaria, L; Schmelz, JL | 1 |
| Ando, T; Katsuya, H; Kidoguchi, K; Kimura, S; Kishimori, C; Kizuka-Sano, H; Kubota, Y; Nishioka, A; Ohno, H; Yamaguchi, K | 1 |
| Brown, AM; Brown, J; Devata, S; Kaminski, MS; Marini, BL; Nachar, VR; Perissinotti, AJ; Phillips, TJ; Weis, TM; Wilcox, RA | 1 |
| Chen, Y; He, HS; Hu, QF; Wang, G | 1 |
| Arora, R; Hildebrandt, GC; Munker, R; Qasrawi, A; Ramlal, R | 1 |
| Ahmed, S; Ahn, KW; Aljurf, M; Bacher, U; Badawy, SM; Bejanyan, N; Cairo, M; Cerny, J; Epperla, N; Farhadfar, N; Fenske, TS; Freytes, CO; Gale, RP; Hamadani, M; Haverkos, B; He, Y; Hossain, N; Inwards, D; Jagadeesh, D; Kamble, RT; Kenkre, VP; Kharfan-Dabaja, MA; Lazarus, HM; Lazaryan, A; Lekakis, L; Litovich, C; Majhail, NS; Mei, M; Murthy, HS; Mussetti, A; Nathan, S; Nishihori, T; Olsson, RF; Ramakrishnan Geethakumari, P; Savani, BN; Sureda, A; Yared, JA | 1 |
| Al-Juhaishi, T; Mckay, J; Sindel, A; Yazbeck, V | 1 |
| Xia, Y; Zhang, X | 1 |
| Aboulafia, D; Ambinder, RF; Cesarman, E; Chadburn, A; Henry, DH; Kaplan, LD; Lee, JY; Mitsuyasu, R; Noy, A; Ramos, JC; Ratner, L; Sparano, JA; Wachsman, W | 1 |
| Chu, JF; Liu, YY; Wang, HY; Wang, K; Yan, Z; Yao, SN; Yao, ZH | 1 |
| Ding, Y; Harada, H; Harada, Y; Hayashi, Y; Ohashi, K; Okuyama, Y; Sadato, D; Shimoyama, T; Shingai, N; Yamaguchi, M | 1 |
| Bartlett, NL; Cheson, BD; Friedberg, JW; Hall, N; Higley, HR; Hsi, ED; Kahl, BS; Kelloff, G; Knopp, MV; Kostakoglu, L; Leonard, JP; Liu, H; Polley, MC; Schöder, H; Schwartz, LH; Wagner-Johnston, N; Wilson, WH; Zelenetz, AD; Zhang, J | 1 |
| Arora, N; Eule, C; Li, HC; Sadeghi, N | 1 |
| Bloigu, R; Haapasaari, KM; Hakalahti, A; Honkavaara, P; Kari, EJM; Karihtala, P; Kuittinen, O; Kuusisto, MEL; Pirinen, R; Teppo, HR; Turpeenniemi-Hujanen, T | 1 |
| Erbin, A; Guler, Y; Ucpinar, B | 1 |
| Chen, H; Hagemeister, FB; He, Y; Li, Y; Manyam, GC; Montes-Moreno, S; Piris, MA; Strati, P; Xiao, L; Xu-Monette, ZY; Young, KH; Zhou, H | 1 |
| Feng, R; Huang, H; Li, J; Liu, P; Shao, C; Sun, Y; Xu, K; Zhang, Y | 1 |
| Amaki, J; Ando, K; Kojima, M; Nakamura, N; Ogiya, D | 1 |
| Afacan Ozturk, HB; Albayrak, M; Comert, P; Malkan, UY; Maral, S; Yildiz, A | 1 |
| Jain, A; Jindal, N; Khadwal, A; Lad, D; Malhotra, P; Prakash, G | 1 |
| Chen, Z; Li, Y; Tian, C | 1 |
| Ddungu, H; Mulumba, Y; Okello, CD; Omoding, A; Orem, J | 1 |
| Imai, Y; Shiseki, M; Tanaka, J; Tanaka, N; Yoshinaga, K | 1 |
| Asano, N; Igarashi, T; Izutsu, K; Katayama, N; Kato, K; Kinoshita, T; Miyawaki, K; Miyazaki, K; Nishikawa, M; Nishikori, M; Nishimura, Y; Ohata, K; Ohshima, K; Okamoto, M; Sakai, R; Sunami, K; Suzumiya, J; Takahashi, N; Tamaru, S; Yamada, T; Yamaguchi, M; Yamamoto, G; Yano, H; Yoshida, I | 1 |
| Aurer, I; Bašić-Kinda, S; Dobrenić, M; Dujmović, D; Galunić-Bilić, L; Hude, I; Ilić, I; Kralik, M; Radman, I; Rončević, P; Sertić, Z; Vodanović, M | 1 |
| Chen, BA; Gao, C; Gu, Y; Wu, X; Zhang, J | 1 |
| Ai, WZ; Andreadis, CB; Damon, L; Fakhri, B; Huang, CY; Hunter, B; Kambhampati, S; Kaplan, L; Martin, T; Pampaloni, M; Varnavski, A | 1 |
| Horan, M; Maddox, JM; Osborne, W; Shrubsole, C; Tafesh, L | 1 |
| Alencar, AJ; Moskowitz, CH | 1 |
| He, B; Peng, Y; Song, X; Sun, X; Wu, Z; Xu, P; Zhu, J | 1 |
| Guan, Y; He, HS; Huang, DP; Liu, Q | 1 |
| Beltrán, B; Castillo, JJ; Castro, D; Huerta, Y; Lalupu, K; Mendoza, R; Pachas, C; Quiñones, MDP | 1 |
| Kuittinen, O; Kuitunen, H; Tokola, S; Turpeenniemi-Hujanen, T | 1 |
| Abou-Ghanem, N; Agab, M; Egoryan, G; Filipiuk, D; Gidron, A; Ibrahim, R; Murguia-Fuentes, R; Pyakuryal, B; Rodriguez-Nava, G; Trelles-Garcia, DP; Yanez-Bello, MA | 1 |
| Beaupre, D; Chhabra, S; de Vos, S; Huang, DW; Kimball, AS; Kwei, K; Neuenburg, JK; Phillips, T; Ping, J; Popplewell, L; Staudt, LM; Wilson, WH; Wright, G | 1 |
| Chung, JS; Kim, DY; Kim, SW; Nam, J; Shin, HJ | 1 |
| Berlangieri, S; Chong, G; Fancourt, T; Hannah, A; Hawkes, E; Lee, ST; Leung, T; Shen, E; Wai, SH; Wight, J | 1 |
| Balzarotti, M; Barretta, F; Cabras, A; Carlo-Stella, C; Carniti, C; Chiappella, A; Cocito, F; Corradini, P; Devizzi, L; Dodero, A; Facchetti, F; Farina, L; Guidetti, A; Marino, F; Miceli, R; Monfrini, C; Monti, V; Pennisi, M; Rahal, D; Re, A; Ricci, F; Rossi, G; Tucci, A | 1 |
| Li, F; Xu, S; Yin, T; Yu, M; Zhang, Q | 1 |
| Choh, S; Iwasa, Y; Katayama, K; Kimura, H; Koguchi, N; Murakami, S; Okada, A; Takahashi, T; Takenaka, H; Tomoda, K | 1 |
| Chinea-Rodríguez, A; Gallego-Rivera, JI; Gorospe, L; Rioja-Martín, ME | 1 |
| Barth, TFE; Bernd, HW; Cogliatti, S; Feller, AC; Hansmann, ML; Hartmann, S; Horn, H; Hummel, M; Klapper, W; Lenz, G; Lenze, D; Löffler, M; Möller, P; Ott, G; Pfreundschuh, M; Rosenwald, A; Schmitz, N; Scott, DW; Staiger, AM; Stein, H; Szczepanowski, M; Trümper, L; Ziepert, M | 1 |
| Harada, Y; Iwasaki, T; Koyama, D; Kurahashi, S; Nishiwaki, S; Sugimoto, T; Sugiura, I; Yamamoto, S | 1 |
| Dunleavy, K; Jaffe, ES; Lai, C; Melani, C; Pack, S; Pittaluga, S; Roschewski, M; Shovlin, M; Steinberg, SM; Wilson, WH | 1 |
| Chen, JL; Dong, LH; Gao, X; Li, GP; Li, YF; Song, YP; Wei, XD | 1 |
| Cassaday, R; Cowan, A; Gopal, A; Kanan, S; Press, O; Reddy, P; Shadman, M; Shustov, A; Smith, SD; Till, B; Warren, H | 1 |
| Jamil, MO; Khelfa, Y; Lebowicz, Y | 1 |
| Afify, Z; Alexander, S; Appel, B; Barth, MJ; Bartlett, NL; Blum, KA; Bollard, CM; Casulo, C; Chen, Z; Christian, B; Dave, H; Davies, K; Forlenza, C; Gardner, R; Giulino-Roth, L; Godfrey, J; LaCasce, A; Leonard, JP; Levine, J; Martin-Doyle, W; Mizukawa, B; O'Donohue, T; Oberley, MJ; Pauly, M; Sima, JL; Smith, SM; Stephens, DM; Svoboda, J; Termuhlen, A; Weitzman, S; Williams, ME; Zeitler, WA | 1 |
| Brown, P; Gang, AO; Høgdall, E; Knudsen, H; Nielsen, SL; Nørgaard, P; Pedersen, M; Pedersen, MØ; Poulsen, T; Wirenfeldt Klausen, T | 1 |
| Anticoli-Borza, P; Arcari, A; Battistini, R; Bocci, G; Casaroli, I; Cox, MC; di Landro, F; Fabbri, F; Merli, F; Musuraca, G; Naso, V; Tafuri, A; Zoli, V | 1 |
| Braziel, RM; Chansky, K; Chen, AI; Dunlap, JB; Fan, G; Gay, ND; Leonard, JT; Maziarz, RT; Okada, CY; Raess, PW; Stentz, A | 1 |
| Belada, D; Bermudez Silva, CD; Bouabdallah, K; Cavalli, F; Costa, LJ; Fan, J; Fayad, L; Hino, M; Ikeda, T; Kattan, JG; Kim, WS; Kuruvilla, J; Larouche, JF; Louveau, AL; Mayer, J; Ogura, M; Ozcan, M; Rigacci, L; Shi, Y; Tobinai, K; Vanazzi, A; Voi, M; Witzig, TE; Wu, C; Zhu, J | 1 |
| Ambinder, RF; Hunter, NB; Vogt, S | 1 |
| Courtien, AI; Devlin, SM; Drullinsky, P; Gerecitano, J; Kumar, A; Matasar, MJ; McCall, SJ; Miller, ST; Moskowitz, CH; Noy, A; Palomba, ML; Portlock, CS; Sauter, CS; Schoder, H; Straus, DJ; Younes, A; Zelenetz, AD | 1 |
| Allan, E; Hanna, F; Khalafallah, AA; Prakash, A | 1 |
| Chen, W; Collins, R; Desai, NB; Li, HC; Patel, P; Rizvi, S; Sadeghi, N; Scaglioni, PP; Trivedi, L; Tumati, V; Vusirikala, M; Wachsmann, J | 1 |
| Hiraga, J; Kagami, Y; Narita, M; Suzuki, N; Takagi, Y; Tomita, A | 1 |
| Chang, J; Hao, SG; Li, GY; Li, ZC; Ma, YJ; Tao, R; Zhang, WH; Zhu, Y | 1 |
| Cao, L; Li, JY; Liang, JH; Lu, RN; Niu, JY; Tian, T; Wang, L; Wu, W; Xu, W; Zhu, HY | 1 |
| Cohen, JB; Flowers, CR; Hall, KH; Panjic, EH; Valla, K | 1 |
| Cao, L; Fan, L; Li, JY; Liang, JH; Wang, L; Wu, W; Xu, W; Zhang, XY; Zhu, HY | 1 |
| Gharaibeh, EZ; Powers, BC; Salacz, ME; Telfah, M | 1 |
| Frost, J; Mini Gill, J; Park, R; Saria, MG | 1 |
| Abramson, JS; Bartlett, NL; Caimi, PF; Dunleavy, K; Fanale, MA; Friedberg, JW; Gaur, R; Hayslip, JW; Jaffe, ES; Jagadeesh, D; Kahl, B; Lacasce, A; Lechowicz, MJ; Little, RF; Lucas, A; Melani, C; Nagpal, S; Noy, A; Parekh, S; Pittaluga, S; Roschewski, M; Steinberg, SM; Wilson, WH | 1 |
| Altmann, B; Friedrichs, B; Glass, B; Haenel, M; Lenz, G; Loeffler, M; Nickelsen, M; Pfreundschuh, M; Rosenwald, A; Ruebe, C; Schmidt, C; Schmitz, N; Viardot, A; Ziepert, M | 1 |
| Bonnet, E; Jaouen, A; Lazareth, A; Maillet, D; Tamarelle, B; Tartas, S; You, B | 1 |
| Jantunen, E; Kuittinen, O; Peroja, P; Prusila, REI; Turpeenniemi-Hujanen, T | 1 |
| Barretta, F; Carniti, C; Corradini, P; Devizzi, L; Di Chio, MC; Dodero, A; Facchetti, F; Guidetti, A; Matteucci, P; Miceli, R; Novo, M; Passi, A; Pellegrinelli, A; Pennisi, M; Pruneri, G; Re, A; Rossi, G; Testi, A; Tucci, A | 1 |
| Bishop, MR; Cohen, KS; Godfrey, JK; Karmali, R; Karrison, T; Kline, JP; Nabhan, C; Rapoport, AP; Smith, SM; Stadler, WM; Venugopal, P | 1 |
| Cai, Y; Jiang, J; Li, S; Song, X; Wan, L; Wang, C; Yang, J; Zhu, J | 1 |
| Haapasaari, KM; Jantunen, E; Kari, E; Karihtala, P; Kuittinen, O; Kuusisto, MEL; Lemma, A; Pirinen, R; Soini, Y; Teppo, HR; Turpeenniemi-Hujanen, T | 1 |
| Barraclough, A; Casan, JM; Hawkes, EA; Shortt, J | 1 |
| Wilson, WH | 1 |
| Beaven, AW; Broadwater, G; Chang, C; Chino, J; Diehl, L; James, O; Kelsey, CR; Koontz, BF; Prosnitz, LR | 1 |
| Abramson, JS; Bartlett, NL; Blum, KA; Chadburn, A; Chang, JE; Cheson, BD; Fisher, RI; Friedberg, JW; Gopal, AK; Hsi, ED; Jung, SH; Kahl, BS; Leonard, JP; Mathew, S; Maurer, MJ; Pederson, LD; Pitcher, BN; Polley, MC; Reddy, NM; Richards, KL; Schöder, H; Staudt, LM; Wagner-Johnston, ND; Wilson, WH; Winter, JN; Zelenetz, AD | 1 |
| Arcari, A; Battistini, R; Bocci, G; Borza, PA; Caridi, M; Casaroli, I; Cox, MC; di Landro, F; Di Napoli, A; Fabbri, F; Marcheselli, L; Musuraca, G; Patti, C; Pelliccia, S; Tafuri, A | 1 |
| Nitta, H | 1 |
| Aránguiz, N; Vega, J | 1 |
| Hirakawa, Y; Iwai, T; Kawaji, Y; Kobayashi, T; Kuriyama, K; Kuroda, J; Muramatsu, A; Nagata, H; Ohshiro, M; Uchiyama, H; Urata, Y | 1 |
| Aladjidi, N; Auperin, A; Couec, ML; Gandemer, V; Haouy, S; Jourdain, A; Lambliotte, A; Landman-Parker, J; Leblanc, T; Michon, J; Minard-Colin, V; Patte, C; Plat, G; Rigaud, C | 1 |
| Chan, EHL; Chee, YL; De Mel, S; Diong, C; Farid Bin Harunal Ras, M; Jeyasekharan, A; Kim, SJ; Koh, LP; Lee, J; Lee, YS; Lim, ST; Liu, X; Poon, LMM; Quek, R; Tan, D; Tang, T; Tao, M | 1 |
| Abramson, JS | 1 |
| Li, L; Liu, X; Meng, B; Qian, Z; Qiu, L; Zhang, H; Zhao, P; Zhou, S | 1 |
| Ambinder, R; Ayala, E; Burns, LJ; Carter, S; Fenske, T; Fisher, R; Horowitz, M; Mineshi, S; Moskowitz, CH; Press, OW; Stadtmauer, EA; Tomblyn, M; Vose, JM | 1 |
| Czuczman, MS | 1 |
| Advani, R; Chen, CC; Dunleavy, K; Grant, C; Hessler, J; Jaffe, ES; Maeda, LS; Pittaluga, S; Staudt, LM; Steinberg, SM; Varma, G; Wilson, WH; Wright, G | 1 |
| Cemerikic-Martinovic, V; Filipovic, B; Marisavljevic, D; Markovic, O; Mihaljevic, B; Radovanović, S; Stanisavljevic, D; Zdravković, M | 1 |
| Choi, MK; Hoon Lim, D; Kang, ES; Kim, DW; Kim, SJ; Kim, WS; Ko, YH; Park, JH; Pyo, DH; Seok, H | 1 |
| Cunningham, D; Linch, DC; Lowry, L; Smith, P | 1 |
| Hasegawa, Y; Itoh, K; Kato, N; Tanaka, T | 1 |
| Chung, JS; Kim, H; Kim, JS; Lee, GW; Lee, HS; Lee, WS; Shin, HJ; Song, MK; Yhim, HY | 1 |
| Hatta, Y; Hirabayashi, Y; Hojo, A; Horikoshi, A; Iriyama, N; Kiso, S; Kobayashi, S; Kobayashi, Y; Kodaira, H; Kura, Y; Kurita, D; Kusuda, M; Miura, K; Nakagawa, M; Sawada, U; Sugitani, M; Takahashi, H; Takei, M; Takeuchi, J; Uchino, Y; Yagi, M | 1 |
| Chihara, D; Chou, T; Hasegawa, Y; Henzan, H; Izutsu, K; Kaneko, H; Kato, K; Kondo, E; Mizuta, S; Sakai, R; Sakamaki, H; Sugahara, H; Suzuki, R; Suzumiya, J; Yokoyama, K | 1 |
| Mullen, EC | 1 |
| Apter, S; Avigdor, A; Ben-Bassat, I; Berkowicz, M; Davidovitz, Y; Davidson, T; Goshen, E; Kedmi, M; Kneller, A; Merkel, D; Nagler, A; Ribakovsy, E; Shimoni, A; Sirotkin, T; Volchek, Y | 1 |
| Beaven, AW; Bejot, C; Bhattacharyya, P; Carini, C; Chow, KF; Donato, ML; Feldman, T; Gadaleta, G; Goy, A; Kdiry, S; Mato, AR; Pecora, AL; Protomastro, EA; Rowley, SD; Smith, J; Stives, S; Timberg, M; Valentinetti, M; Yang, X; Yannotti, KM | 1 |
| Auger-Quittet, S; Daures, JP; Duny, Y; Quittet, P | 1 |
| Andreola, G; Babic, A; Frungillo, N; Gardellini, A; Laszlo, D; Martinelli, G; Montoro, J; Negri, M | 1 |
| An, ZM; Li, F; Liu, HN; Song, P; Wang, LP; Yang, XY; Yu, YP; Zhai, YP; Zhou, XG | 1 |
| Lee, JC; Lerner, A; Pestana, JB; Tapan, U | 1 |
| Fellowes, A; Hanna, DM; Hansford, JR; Mechinaud, F; Vedururu, R | 1 |
| Ascani, S; Capodanno, I; Ragazzi, M; Valli, R; Zanelli, M | 1 |
| Imai, K; Kato, T; Miyao, K; Niimi, K; Ono, Y; Sakai, T; Sakemura, R; Sawa, M; Tsushita, N | 1 |
| Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A | 1 |
| Kadowaki, M; Kohno, K; Kondo, S; Kubota, A; Okamura, S; Takase, K; Takeshita, M; Tanimoto, K; Yamasaki, S | 1 |
| Arranz, R; Bargay, J; Bello, JL; Caballero, MD; Conde, E; Coronado, M; González-Barca, E; Grande, C; Hernández, MT; Marín-Niebla, A; Martín, A; Montes-Moreno, S; Panizo, C; Pardal, E; Pérez-Ceballos, E | 1 |
| Burbury, K; Carney, DA; Cheah, CY; Dickinson, M; Fedele, PL; George, A; Gilbertson, M; Harrison, SJ; Herbert, KE; Januszewicz, EH; Kennedy, GA; O'Rourke, K; Opat, SS; Prince, HM; Ritchie, DS; Seymour, JF; Tam, CS; Tan, SY; Westerman, DA; Wolf, M | 1 |
| Ancochea, Á; Fernández-Rodriguez, C; García-Pallarols, F; Gimeno, E; Salar, A; Sánchez-González, B | 1 |
| Maruyama, D | 2 |
| Cella, D; Drullinsky, PR; Elstrom, R; Gerecitano, JF; Hamilton, AM; Hamlin, PA; Lia Palomba, M; Matasar, MJ; Noy, A; Straus, DJ; Wegner, B; Wortman, K; Zelenetz, AD | 1 |
| Brown, P; Gang, AO; Høgdall, E; Klausen, TW; Knudsen, H; Lauritzen, AF; Nielsen, SL; Nørgaard, P; Pedersen, M; Pedersen, MØ | 1 |
| Enblad, G; Hagberg, O; Hedström, G; Jerkeman, M | 1 |
| Batlle, A; Bergua, J; Carnicero, F; Castellví, J; de Villambrosia, SG; Ferrando-Lamana, L; Gallur, L; García-Marco, JA; Lopez, A; Lopez, LA; Montes-Moreno, S; Piris, MA; Prieto, J; Purroy, N; Sancho, JM | 1 |
| Castillo, JJ; Reagan, JL; Sikov, WM; Winer, ES | 1 |
| Advani, P; Foran, J; Garner, H; Goff, R; Jain, M; Jiang, L; Murray, P; Paulus, A; Pooley, R | 1 |
| Advani, R; Ansell, SM; Bartlett, NL; Belada, D; Coiffier, B; Drachman, JG; Fayad, L; Forero-Torres, A; Kuliczkowski, K; Ng, E; Stuart, R | 1 |
| Allen, PK; Arzu, I; Dabaja, B; Fayad, LE; Medeiros, LJ; Oki, Y; Pinnix, CC; Reed, VK; Rodriguez, A; Shihadeh, F; Tao, R; Westin, JR | 1 |
| Advani, RH; Gascoyne, R; Habermann, TM; Hong, F; Horning, SJ; Kahl, BS; Li, H; Quon, A; Ranheim, EA; Swinnen, LJ | 1 |
| Advani, RH; Hiniker, SM; Hoppe, RT; Khodadoust, MS; Kozak, MM; Pollom, EL; Quon, A; Xu, G | 1 |
| Ahmed, MA; Ahmed, S; Chuang, HH; Costelloe, C; Dabaja, B; Davis, RE; Fanale, MA; Fayad, L; Fowler, N; Hagemeister, FB; Khouri, IF; Medeiros, LJ; Nastoupil, L; Neelapu, S; Nieto, Y; Oki, Y; Pinnix, CC; Reed, V; Rodriguez, MA; Romaguera, JE; Turturro, F; Westin, J; Wogan, CF | 1 |
| Esiashvili, N; Flowers, CR; Jegadeesh, N; Khan, MK; Liu, Y; Okwan-Duodu, D; Rajpara, R; Shi, Z | 1 |
| Brown, P; Gang, AO; Høgdall, E; Knudsen, H; Lauritzen, AF; Nielsen, SL; Nørgaard, P; Pedersen, M; Pedersen, MØ; Poulsen, TS | 1 |
| Kapuria, D; Qasem, A; Strasser, K | 1 |
| Abramson, JS; Adeimy, C; Advani, RH; Al-Mansour, Z; Bartlett, NL; Blum, KA; Caimi, PF; Evens, AM; Fabregas, JC; Feldman, T; Fenske, TS; Friedberg, JW; Gascoyne, RD; Hemminger, J; Hernandez-Ilizaliturri, FJ; Kanakry, JA; Klein, AK; Kritharis, A; Kroll, A; Lossos, IS; Mato, A; Nabhan, C; Petrich, AM; Press, OW; Sehn, LH; Smith, SM; Vose, JM | 1 |
| Caimi, PF; Campagnaro, EL; Cooper, BW; Creger, RJ; de Lima, M; Fox, R; Fu, P; Gerson, SL; Lazarus, HM; Reese-Koc, J; Silva Rondon, CH; William, BM | 1 |
| Alamoudi, S; Anglin, P; Baetz, T; Chen, BE; Cheung, M; Couban, S; Crump, M; Djurfeldt, MS; Hay, AE; Ismail, WS; Kouroukis, CT; Kuruvilla, J; Luminari, S; MacDonald, DA; Meyer, RM; Olney, HJ; Seftel, M; Shepherd, L; Turner, AR | 1 |
| Advani, RH; Binkley, MS; Hiniker, SM; Hoppe, RT; Mittra, ES; Natkunam, Y; Wu, S | 1 |
| Beshlawi, I; Bhuyan, D; El-Banna, N; Elmanzalawy, A; Rabah, F | 1 |
| Bi, XW; Huang, HQ; Huang, JJ; Jiang, WQ; Li, YJ; Li, ZM; Lin, TY; Song, CG; Wang, Y; Xia, Y | 1 |
| Hartman, L; Jerkeman, M; Székely, E; Wästerlid, T | 1 |
| Hansen, PB; Thomsen, RH; Zakarian, K | 1 |
| Ikebe, T; Ogata, M; Saburi, Y; Sasaki, H | 1 |
| Dong, L; Du, J; Gao, X; Li, G; Li, Y; Song, Y; Sun, X; Wei, X; Xu, B | 1 |
| Abramson, JS; Cassaday, R; Chavez, JC; Fenske, TS; Gandhi, M; Jaso, J; Landsburg, DJ; Medeiros, LJ; Nabhan, C; Petrich, AM; Press, O; Shah, N; Sohani, AR; Song, K; Yang, DT; Zelenetz, AD | 1 |
| Advani, R; Constine, LS; Dabaja, BS; Dhakal, S; Flowers, CR; Ha, CS; Hodgson, DC; Hoppe, BS; Mendenhall, NP; Metzger, ML; Plastaras, JP; Roberts, KB; Shapiro, R; Smith, SM; Terezakis, SA; Winkfield, KM; Younes, A | 1 |
| Ahlman, MA; Grayson, PC; Hughes, M; Malayeri, AA; Newman, KA; Pratt, D | 1 |
| Dunleavy, K | 1 |
| Avivi, I; Gibstein, L; Herishanu, Y; Joffe, E; Perry, C; Polliack, A; Sarid, N | 1 |
| Amorim, S; Brice, P; Fleury, I; Harel, S; Mounier, N; Thieblemont, C | 1 |
| Caballero, D; Canales, M; Dlouhy, I; González-Barca, E; López-Guillermo, A; Martín, A; Montes-Moreno, S; Ocio, EM; Redondo, AM; Salar, A | 1 |
| Gao, J; Guo, J; Guo, X; Jia, CS; Li, Q; Zhou, CY; Zhu, YP | 1 |
| Eto, T; Fujisaki, T; Fukuda, T; Harada, M; Hidaka, T; Iyama, S; Maeda, Y; Miyamoto, T; Murayama, T; Nagafuji, K; Okumura, H; Sawazaki, A; Sunami, K; Takatsuka, Y; Tsuda, H; Tsuneyoshi, N; Tsurumi, H; Uike, N | 1 |
| Liu, YF | 1 |
| Bi, XW; Huang, JJ; Jiang, WQ; Li, ZM; Lin, TY; Liu, PP; Sun, P; Wang, Y; Xia, Y | 1 |
| Huang, YQ; Ma, XD; Wu, RJ; Zheng, RJ | 1 |
| Jaeger, U; Mayerhoefer, M; Porpaczy, E; Salzer-Muhar, U | 1 |
| Guo, YX; Hu, RH; Hui, WH; Su, L; Sun, WL; Wan, SG; Zhao, H | 1 |
| Desai, P; Li, S; Lin, P; Medeiros, LJ; Oki, Y; Saksena, A; Tang, G; Thakral, B; Xu, J; Yin, CC; You, MJ | 1 |
| Björkholm, M; Borrebaeck, CA; Eriksson, M; Fjordén, K; Fluge, Ø; Holte, H; Isinger-Ekstrand, A; Jerkeman, M; Leppä, S; Møller Pedersen, L; Pauly, F; Wingren, C | 1 |
| Desai, P; Hu, B; Hu, S; Khoury, JD; Li, S; Lin, P; Loghavi, S; Medeiros, LJ; Oki, Y; Tang, G; Thakral, B; Xu, J; Yin, CC | 1 |
| Butcher, B; Chong, G; Cull, G; Fay, K; Filshie, R; Gandhi, MK; Gill, D; Grigg, A; Hahn, U; Hertzberg, M; Hicks, RJ; Ho, SJ; Hofman, MS; Johnston, A; Kannourakis, G; Lewis, ID; Milliken, S; Renwick, W; Seymour, JF; Taper, J; Trotman, J; Warburton, P; Watson, AM; Wirth, A | 1 |
| Ajduković, R; Jakšić, O; Kušec, R; Lucijanić, M; Mitrović, Z; Pejša, V; Piršić, M; Prka, Ž | 1 |
| Canter, DJ; Patel, RD; Walker, C | 1 |
| Chen, JY; Lu, C; Tang, X; Wang, JW | 1 |
| Ariyoshi, N; Kitada, M; Koga, H; Nakamura, H; Nakasa, H; Nakaseko, C; Nishimura, M; Saeki, H; Suzuki, T; Tanaka, H; Yamazaki, S | 1 |
| Ansell, SM; Costa, LJ; Inwards, DJ; Johnston, PB; Litzow, MR; Micallef, IN; Porrata, LF | 1 |
| Ferreri, AJ; Foppoli, M; Mazzucchelli, L; Ponti, G; Ponzoni, M; Zucca, E | 1 |
| Alinari, L; Baccarani, M; Derenzini, E; Fanti, S; Gandolfi, L; Musuraca, G; Stefoni, V; Tani, M; Venturini, F; Zinzani, PL | 1 |
| Andreu, R; Arnan, M; Caballero, MD; Canales, MA; Conde, E; Deben, G; Donato, EM; García-Sanchez, P; González, JA; González-Barca, E; Grande, C; León, A; Martín, A; Nistal, S; Requena, MJ; Ruiz, C; Salar, A; Sancho, JM; Vázquez, L | 1 |
| Brault, P; Decaudin, D; Escande, MC; Girodet, J; Mariani, P; Mathiot, C; Precupanu, CM; Zanni, M | 1 |
| Cho, GJ; Chung, JS; Joo, YD; Kim, KH; Kim, YS; Lee, WS; Shin, HJ; Shin, SH; Sohn, CH | 1 |
| Caballero, MD; Martín, A | 1 |
| Chiba, T; Ichinohe, T; Kadowaki, N; Marusawa, H; Uchiyama, T; Ueda, Y | 1 |
| Bhartia, S; Proctor, SJ; Sieniawski, M; Wilkinson, J | 1 |
| Conrad, AL; Go, RS | 1 |
| Haapasaari, KM; Kuittinen, O; Kyllönen, H; Pasanen, AK; Turpeenniemi-Hujanen, T | 1 |
| Broccoli, A; Brusamolino, E; Cabras, MG; Chiappella, A; Finolezzi, E; Martelli, M; Rossi, A; Salvi, F; Stefoni, V; Zinzani, PL | 1 |
| Kinoshita, T | 1 |
| Cen, XN; Chen, H; Han, MZ; Han, XH; He, XH; Huang, H; Huang, HQ; Jiang, WQ; Liu, P; Ma, J; Ren, HY; Shen, XM; Shi, YK; Wang, C; Wang, JM; Yang, S; Zhou, SY; Zhu, J | 1 |
| Blumenfeld, Z; Zuckerman, T | 1 |
| Carrasquillo, JA; Dunleavy, K; Grant, N; Jaffe, ES; Little, RF; Pittaluga, S; Steinberg, SM; Wayne, AS; Wilson, WH; Yarchoan, R | 1 |
| Boesen, AM; Browett, P; Cunningham, D; Grigg, A; Hancock, B; Holte, H; Hoskin, P; Jack, A; Linch, DC; Maclennan, K; Qian, W; Smith, P; Trneny, M; Yung, L | 1 |
| Bessho, M; Hagiwara, Y; Kohri, M; Niitsu, N; Okamoto, M; Takahashi, N; Tanae, K | 1 |
| Avilés, A; de Jesús Nambo, M; Huerta-Guzmán, J; Neri, N | 1 |
| Ali, ZB; Ben Othmen, T; Bouaouina, N; Daoud, J; Elloumi, M; Ghannem, H; Laatiri, MA; Maalej, M; Meddeb, B; Msadek, F; Toumi, N | 1 |
| Kiewe, P; Thiel, E | 1 |
| Feller, A; Freund, M; Glass, B; Loeffler, M; Metzner, B; Pfreundschuh, M; Reiser, M; Schmitz, N; Trümper, L; Ziepert, M | 1 |
| Apperley, JF; Auner, HW; Contento, A; Ellis, S; Giles, C; Kanfer, EJ; MacDonald, DH; Naresh, K; Pavlů, J; Rahemtulla, A; Szydlo, RM | 1 |
| Bosly, A; Brière, J; Gisselbrecht, C; Glass, B; Hagberg, H; Ketterer, N; Linch, DC; Ma, D; Moskowitz, CH; Mounier, N; Schmitz, N; Shpilberg, O; Singh Gill, D; Trneny, M | 1 |
| Bosly, A; Brière, J; Coiffier, B; Gisselbrecht, C; Molina, T; Morel, P; Mounier, N; Munck, JN; Quesnel, B; Ranta, D; Reyes, F; Thyss, A; Tilly, H | 1 |
| Nakamine, H; Nakamura, N; Nakamura, S; Niitsu, N; Ohshima, K; Okamoto, M; Tamaru, J; Yoshino, T | 1 |
| Hagiwara, Y; Kohri, M; Niitsu, N; Takahashi, N; Tanae, K | 1 |
| Hosokai, R; Imai, C; Imamura, M; Iwabuchi, H; Takachi, T; Uchiyama, M; Yoshida, S | 1 |
| Brown, PDN; Bukh, A; d'Amore, F; Gadeberg, OV; Gang, AO; Ingeberg, S; Moeller, MB; Mortensen, LS; Mourits-Andersen, T; Pedersen, BB; Pedersen, LM; Pedersen, M; Pulczynski, S; Strøm, C | 1 |
| Choi, CW; Choi, YJ; Jung, KY; Kim, BS; Kim, SJ; Lee, SR; Park, KH; Park, SJ; Park, Y; Sung, HJ | 1 |
| Akao, Y; Horiike, S; Kobayashi, S; Kobayashi, T; Kuroda, J; Matsumoto, Y; Nagoshi, H; Nishida, K; Sasaki, N; Shimura, Y; Taki, T; Taniwaki, M; Tsutsumi, Y; Yamamoto, M | 1 |
| Homma, C; Miwa, A; Sekiguchi, N; Shikai, T; Takezako, N; Takezako, Y; Tanimura, A; Yamagata, N | 1 |
| Boudova, L; Briere, J; Bron, D; Chevalier, C; Cogliatti, S; Cuccuini, W; Gaulard, P; Gisselbrecht, C; Hirchaud, E; Houlgatte, R; Jack, A; Mounier, N; Rosenwald, A; Schmitz, N; Soulier, J; Sundstrom, C; Thieblemont, C; Trougouboff, P; Voelker, HU; Ysebaert, L | 1 |
| Canellos, G; Chadburn, A; Cheson, BD; Czuczman, M; Dunleavy, K; Hsi, ED; Hurd, D; Johnson, J; Jones, D; Jung, SH; Lai, R; Martin, SE; Porcu, P; Said, J; Wilson, WH; Zelenetz, AD | 1 |
| Andemariam, B; Coleman, M; Elstrom, RL; Furman, RR; Leonard, JP; Martin, P; Ruan, J; Shore, TB | 1 |
| Camilleri, MJ; Podjasek, JO | 1 |
| Briere, J; Bron, D; Cogliatti, S; Cuccuini, W; Gaulard, P; Gisselbrecht, C; Hirchaud, E; Houlgatte, R; Mounier, N; Rosenwald, A; Soulier, J; Sundstrom, C; Thieblemont, C; Voelker, HU; Ysebaert, L | 1 |
| Ardeshna, K; Kayani, I; Linch, DC; Lowry, L; Moore, S; Peggs, K; Qian, W; Thomson, K | 1 |
| Crisel, RK; Kim, SS; Knight, BP | 1 |
| Papavassiliou, P; Sebastian, S; Wang, E | 1 |
| D'Souza, R; Khan, F; McKimm, E; Vessal, S | 1 |
| al-Farsi, K; Crump, M; Keating, A; Kuruvilla, J; Puig, N; Seshadri, T; Wang, L | 1 |
| Granell, M; Mozos, A; Pajares, V; Puzo, C; Szafranska, J; Torrego, A | 1 |
| Baum, LG; Clark, MC; de Vos, S; Gascoyne, RD; Hsu, DK; Liu, FT; Pang, M; Said, J | 1 |
| Assanelli, A; Baldini, L; Caligaris-Cappio, F; Ferrari, A; Ferreri, AJ; Foppoli, M; Frezzato, M; Frungillo, N; Ilariucci, F; Licata, G; Mappa, S; Marturano, E; Proserpio, I; Reni, M; Sorarù, M; Stelitano, C; Vianello, F | 1 |
| Arribas, I; Burgaleta, C; Callejas, M; Casco, CR; Curto, N; Flores, E; García-Suárez, J; Gil-Fernández, JJ; Guillén, H; Martín, Y; Olmedilla, G | 1 |
| Gisselbrecht, C | 1 |
| Cheng, AL; Huang, HC; Kuo, SH; Lin, CW | 1 |
| Anderson, H; Björkholm, M; Delabie, J; Eriksson, M; Erlanson, M; Fluge, O; Fosså, A; Holte, H; Janes, R; Jerkeman, M; Jyrkkiö, S; Karjalainen-Lindsberg, ML; Kolstad, A; Leppä, S; Löfvenberg, E; Nordström, M; Ostenstad, B; Pedersen, LM; Sundström, C | 1 |
| Campr, V; Kozak, T; Mocikova, H; Palickova, M; Vernerova, Z | 1 |
| Fujii, H; Iwai, T; Nakagawa, H; Ueda, Y | 1 |
| Auroux, J; Bernardeau, M; Cavicchi, M; Delchier, JC; Haioun, C; Tsakiris, L | 1 |
| Clemente González, C; García Parés, D; García-Bragado Dalmau, F; Guardia Sánchez, R; Pérez Ayuso, MJ; Porcar Ramells, C | 1 |
| Berkow, RL; Hilliard, LM; Watts, RG | 1 |
| Albó, C; Arranz, R; Caballero, MD; Cabrera, R; Carreras, E; Conde, E; Fernández de Sevilla, A; Gandarillas, M; García Ruíz, JC; García-Conde, J; García-Laraña, J; Grande, C; Iriondo, A; Lahuerta, JJ; Marín, J; Moraleda, JM; Pérez-Equiza, C; Pérez-Simón, JA; Rifón, J; Rubio, V; San Miguel, JF; Sierra, J; Sureda, A; Varela, R; Vidal, MJ; Zuazu, J | 1 |
| Alterini, R; Bellesi, G; Bernardi, F; Bosi, A; Carpaneto, A; Carrai, V; Longo, G; Rigacci, L; Rossi Ferrini, P | 1 |
| Franchini, G; Grant, N; Gutierrez, M; Jaffe, ES; Kavlick, MF; Little, RF; Mitsuya, H; Pittaluga, S; Raffeld, M; Shearer, G; Steinberg, SM; Wilson, WH; Yarchoan, R | 1 |
| Crump, M; Keating, A; Mollee, P; Song, KW | 1 |
| Hamlin, PA; Kewalramani, T; Moskowitz, CH; Nimer, SD; Noy, A; Portlock, CS; Qin, J; Satagopan, JM; Straus, DJ; Verbel, D; Yahalom, J; Zelenetz, AD | 1 |
| Lauterbach, I; Mann, G; Niemeyer, C; Parwaresch, R; Reiter, A; Riehm, H; Schrappe, M; Seidemann, K; Simonitsch, I; Stankewitz, K; Tiemann, M; Zimmermann, M | 1 |
| Kadowaki, S; Kawakami, K; Watanabe, Y | 1 |
| Bittner, S; Kloess, M; Loeffler, M; Pfreundschuh, M; Reiser, M; Rudolph, C; Schmalenberg, H; Schmits, R; Truemper, L; Wunderlich, A | 1 |
| Alinari, L; Baccarani, M; Stefoni, V; Vianelli, N; Zinzani, PL | 1 |
| Arima, N; Arimura, K; Hamada, H; Kukita, T; Matsushita, K; Tei, C | 1 |
| Ambrosetti, A; Cabras, MG; Di Vito, F; Fioritoni, G; Gabbas, A; Gallamini, A; Gallo, E; Gargantini, L; Gottin, L; Lazzarino, M; Menestrina, F; Morra, E; Orlandi, E; Palestro, M; Pasini, F; Paulli, M; Pizzolo, G; Pizzuti, M; Rossi, G; Secchi, S; Tarella, C; Tecchio, C; Todeschini, G; Vitolo, U | 1 |
| Filippa, DA; Gencarelli, A; Kewalramani, T; Moskowitz, CH; Nimer, SD; Noy, A; O'Connor, O; Portlock, C; Qin, J; Straus, D; Teruya-Feldstein, J; Waxman, A; Yahalom, J; Zelenetz, AD | 1 |
| Kitawaki, T; Nishikori, M; Ohno, H; Uchiyama, T; Ueda, C | 1 |
| Betticher, DC; Egli, F; Honegger, HP; Jacky, E; Jermann, M; Jost, LM; Kroner, T; Stahel, RA; Taverna, Ch | 1 |
| Hoang-Xuan, K; Levy, V; Soussain, C | 1 |
| Bergmann, L; Hübinger, G; Kirchner, D; Müller, E; Ruff, H; Schmid, M; Schneider, C; Schwänen, C; Stöhr, D | 1 |
| Blystad, AK; Delabie, J; Holte, H; Ikonomou, I; Kvalheim, G; Kvaløy, S; Vålerhaugen, H | 1 |
| Grant, N; Gutierrez, M; Jaffe, ES; Janik, JE; McDonald, K; Morris, JC; Pittaluga, S; Raffeld, M; Waldmann, TA; Wilson, WH | 1 |
| Holte, H; Jerkeman, M; Kvaløy, S; Leppä, S | 1 |
| Annunziata, M; Copia, C; D'Amico, MR; De Simone, M; Ferrara, F; Mele, G; Palmieri, S; Pocali, B; Schiavone, EM; Viola, A | 1 |
| Cillessen, SA; Gundy, C; Jansen, PM; Jiwa, NM; Kluin-Nelemans, HC; Kummer, JA; Meijer, CJ; Muris, JJ; Ossenkoppele, GJ; Oudejans, JJ; van Houdt, IS; van Krieken, JH; Vos, W | 1 |
| Deák, B; Eid, H; Esik, O; Horváth, A; Horváth, GI; Keresztes, S; Lengyel, Z; Lovey, J; Molnár, Z; Rosta, A; Schneider, K; Schneider, T; Tóth, E; Várady, E | 1 |
| Carde, P; Ferme, C; Girinsky, T; Koscielny, S; Lapusan, S; Ribrag, V | 1 |
| Fukushima, T; Hirose, Y; Itoh, H; Karasawa, H; Kawabata, H; Kojima, Y; Masaki, Y; Ogawa, N; Sawaki, T; Shimoyama, K; Sugai, S; Sutoh, H; Wano, Y | 1 |
| Meijer, CJ; Muris, JJ; Oudejans, JJ | 1 |
| Bazari, H; Forman, JP; Humphreys, BD; Magee, CC; Seifter, J; Zandi-Nejad, K | 1 |
| Nath, SV; Seymour, JF | 1 |
| Akçören, Z; Büyükpamukçu, M; Kiratli, H; Köksal, Y; Varan, A | 1 |
| Aversa, S; Billio, A; Brunori, M; Candela, M; Centurioni, R; Chisesi, T; Congiu, AM; Contu, A; Crugnola, M; De Souza, C; Majolino, I; Marino, G; Nati, S; Olivieri, A; Patti, C; Porcellini, A; Rubagotti, A; Santini, G; Sertoli, MR; Spriano, M; Tedeschi, L; Vimercati, R | 1 |
| Enschede, SH; Gregory, SA; Larson, ML | 1 |
| Al-Rajhi, N; Connors, JM; Gascoyne, RD; Klasa, R; Paltiel, C; Savage, KJ; Voss, N | 1 |
| Aoyama, Y; Hagihara, K; Hino, M; Hirai, M; Hirose, A; Kanashima, H; Koh, KR; Kosaka, S; Kumura, T; Manabe, M; Mugitani, A; Nakajima, Y; Nakamae, M; Nakao, Y; Ohta, K; Sakamoto, C; Sakamoto, E; Terada, Y; Teshima, H; Yamane, T | 1 |
| Akhtar, S; El Weshi, A; Humaidan, H; Maghfoor, I; Rahal, M; Tbakhi, A | 1 |
| Broglia, C; Corazza, GR; Federico, M; Gobbi, PG; Lambelet, P; Lombardo, M; Luminari, S; Mammi, C; Merli, F; Polimeno, G; Riezzo, A; Rovati, A; Valentino, F | 1 |
| Bohlius, J; Engert, A; Hülsewede, H; Kober, T | 1 |
| Ambrosetti, A; Andreoli, A; Canal, F; Chilosi, M; Krampera, M; Lestani, M; Parolini, C; Pizzolo, G; Visco, C | 1 |
| Kageyama, Y; Kihara, K; Kobayashi, T; Kubo, Y; Yokoyama, M | 1 |
| Benson, W; Bradstock, KF; Crombie, C; Gottlieb, D; Hertzberg, MS; Taper, J | 1 |
| Gisselbrecht, C; Hagberg, H | 1 |
| Aurran, T; Biron, P; Bouabdallah, R; Boulat, O; Chabannon, C; Chetaille, B; Coso, D; Esterni, B; Gastaut, JA; Ivanov, V; Maraninchi, D; Rey, J; Schiano de Collela, JM; Sebban, C; Stoppa, AM; Xerri, L | 1 |
| Amin, HM; Atwell, C; Drakos, E; Medeiros, LJ; Oyarzo, MP; Rassidakis, GZ | 1 |
| Dabbas, B; Ford, CD; Gabor, F; Morgan, R | 1 |
| Kotani, T; Nakamura, Y; Ueda, M; Yamaguchi, M | 1 |
| Beitler, B; Chamone, DA; Chaoubah, A; Dulley, FL; Hallack Neto, AE; Llacer, PD; Macedo, MC; Pereira, J | 1 |
| Arribas, I; Bañas, H; Burgaleta, C; De Miguel, D; García-Suárez, J; Pascual, T | 1 |
| Leonard, JP; Siegel, AB | 1 |
| Baldini, L; Bertini, M; Botto, B; Cabras, G; Di Vito, F; Federico, M; Gallo, E; Liberati, AM; Luminari, S; Marcheselli, L; Merli, F; Mozzana, R; Naglieri, E; Orsucci, L; Pennese, E; Polimeno, G; Vitolo, U | 1 |
| Benaroush, M; Blumenfeld, Z; Zuckerman, T | 1 |
| Barberi, W; Foa, R; Giona, F; Malandruccolo, L; Mandelli, F; Martino, P; Moleti, ML; Palumbo, G; Paoloni, F; Pescarmona, E; Testi, AM | 1 |
| Bene, MC; Casasnovas, O; Debard, AL; Delfau-Larue, MH; Emile, JF; Farcet, JP; Feugier, P; Gisselbrecht, C; Haioun, C; Jais, JP; Kuhlein, E; Labalette, M; Plonquet, A; Rabian, C; Salles, G | 1 |
| Hussein, MR; Omer, HA | 1 |
| Boccadoro, M; Bregni, M; Cabras, A; Calvi, R; Caracciolo, D; Comino, A; Corradini, P; Devizzi, L; Di Nicola, M; Fornari, A; Gallamini, A; Gianni, AM; Ladetto, M; Magni, M; Majolino, I; Mirto, S; Novero, D; Patti, C; Pescarollo, A; Ponzoni, M; Remotti, D; Rosato, R; Stella, M; Tarella, C; Zanni, M; Zoli, V | 1 |
| Akutsu, M; Inoue, K; Izumi, T; Kano, Y; Katano, S; Kobayashi, H; Masuda, Y; Muroi, K; Nagashima, T; Ohmine, K; Ozawa, K; Shirai, T; Takagi, S; Tsunoda, S; Ueda, M; Ueda, T | 1 |
| Koizumi, K; Kondo, M; Minauchi, K; Mukai, M; Odani, T; Takada, A | 1 |
| Ansell, SM; Colgan, JP; Habermann, TM; Inwards, DJ; Johnston, PB; Markovic, SN; Micallef, IN; Porrata, LF; Ristow, KM; Simpson, L; Witzig, TE | 1 |
| Dham, SK; Gelfand, Y; Nagajothi, N; Sanmugarajah, J | 1 |
| Carlson, N; Dal Cin, P; Deng, J; Letai, A; Shipp, M; Takeyama, K | 1 |
| Afanasyeva, EA; Bahram, F; Guzhova, IV; Komarova, EY; Larsson, LG; Margulis, BA | 1 |
| Castricum, KC; Cillessen, SA; Deurhof, J; Hess, CJ; Hooijberg, E; Houghten, R; Kortman, P; Meijer, CJ; Ossenkoppele, GJ; Oudejans, JJ; Pinilla, C; Reed, JC; Welsh, K | 1 |
| Alinari, L; Baccarani, M; Bacci, F; Derenzini, E; Fina, M; Marchi, E; Musuraca, G; Pellegrini, C; Pileri, S; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Castricum, KC; Cillessen, SA; Denkers, F; Hess, CJ; Hooijberg, E; Kortman, P; Meijer, CJ; Ossenkoppele, GJ; Oudejans, JJ; Schuurhuis, GJ; van de Wiel, MA; Vos, W | 1 |
| Albo, C; Alonso, N; Arranz, R; Caballero, D; Conde, E; Fernández-Rañada, JM; Gandarillas, M; García Vela, JA; Garzón, S; Grande, C; Hernández, MT; Lahuerta, JJ; Mateos, MV; Rodríguez, J | 1 |
| Clotagatide, A; Dubois, F; Le Jeune, N; Perek, N; Prevot, N; Sabido, O; Vergnon, JM | 1 |
| Al-Saleem, T; Jambusaria, A; Perlis, C; Shafer, D; Wu, H | 1 |
| Chabner, BA; Dunleavy, K; Grant, N; Gutierrez, M; Hegde, U; Jaffe, ES; Janik, JE; Pittaluga, S; Raffeld, M; Staudt, L; Steinberg, SM; Wilson, WH | 1 |
| Casasnovas, O; Choquet, S; Dupriez, B; Fourme, E; Gisselbrecht, C; Hoang-Xuan, K; Jaccard, A; Janvier, M; Kolb, B; Leblond, V; Omuro, A; Sanson, M; Souleau, B; Soussain, C; Taillandier, L; Taksin, AL; Witz, F; Zini, JM | 1 |
| Barbui, T; Benedetti, F; Boccadoro, M; Ciceri, F; Corradini, P; Cortelazzo, S; Gallamini, A; Gianni, AM; Magni, M; Majolino, I; Mirto, S; Passera, R; Patti, C; Pileri, A; Pizzolo, G; Rambaldi, A; Tarella, C; Zanni, M | 1 |
| Bodey, GP; Burgess, MA; Cabanillas, F; Freireich, EJ | 1 |
| Ino, T; Kojima, H; Maruyama, F; Matsui, T; Miyazaki, H; Nomura, T; Okamoto, M; Sobue, R; Tsuzuki, M; Wakita, M | 1 |
| Lishner, M; Slingerland, J; Sutcliffe, SB; Theresa, C | 1 |
| Hagiwara, Y; Hayakawa, T; Kanayama, T; Miyawaki, Y; Nakagawa, H; Tokiyoshi, K; Tsuruzono, K; Yamada, M | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Nambo, MJ; Talavera, A | 1 |
| Brugger, W; Engelhardt, R; Kanz, L; Mertelsmann, R | 1 |
| Cooper, DL; Flynn, SD; Reale, MA; Strair, RK; Yen, Y | 1 |
| Cabanillas, F; Cortes, JE; Kurzrock, R; Seymour, JF; Talpaz, M | 1 |
| Fields, LL; Maziarz, RT; White, CR | 1 |
| Greco, FA; Greer, JP; Hainsworth, JD; Waits, TM | 1 |
| Hayashi, K; Kawashima, K; Matsutomo, S; Mizuta, J; Ohnoshi, T; Saito, S; Tada, A; Tagawa, S; Ueno, K; Yoshino, T | 1 |
| Addante, RR; Daniels, CA; Loomer, L; Schaberg, SJ | 1 |
| Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW | 1 |
| Brice, P; Castaigne, S; Gisselbrecht, C; Marolleau, JP; Pautier, P | 1 |
| Connors, JM; Hoskins, P; Howdle, S; Klasa, R; Klimo, P; O'Reilly, SE; Stuart, DS | 1 |
| Bapat, A; Goldberg, J; Goldman, N; Gordon, R; Gryn, J | 1 |
| Fukuhara, S; Fushimi, H; Kameyama, M; Komaki, N; Ohkuma, M; Sakoda, H; Usami, M; Yoshida, H | 1 |
| Aggarwal, BB; Gallati, H; Loetscher, H; Mihalik, R; Penzes, M; Pocsik, E | 1 |
| Hirokawa, M; Lee, M; Miura, AB; Motegi, M | 1 |
| Adde, MA; Arndt, C; Gootenberg, J; Horak, ID; Magrath, IT; Neely, JE; Nieder, ML; Seibel, NL; Shad, AT; Venzon, DJ; Weintraub, M | 1 |
| Cleary, ML; Davis, RE; Kamel, OW; Soslow, RA; Warnke, RA | 1 |
| Anderson, L; Cunningham, DC; Gregory, WM; Hancock, BW; Hoskin, PJ; Linch, DC; MacLennan, KA; Milligan, DW; Newland, AC; Stevenson, PA; Vaughan Hudson, B; Vaughan Hudson, G; Wood, JK | 1 |
| DaSilva, V; Dent, S; Eapen, L; Girard, A; Hugenholtz, H; Stewart, DJ | 1 |
| Byrnes, JJ; Cabral, L; Fletcher, MA; Freidlander, A; Harrington, WJ; Patarca, R | 1 |
| Amigo, ML; Caballero, D; del Cañizo, C; Revilla, R; San Miguel, JF; Sánchez, C | 1 |
| Andersen, J; Bauer, KD; Fisher, RI; Gordon, LI; Jiang, S; Neiman, RS; Oken, MM; Variakojis, D; Winter, JN | 1 |
| Azar, N; Binet, JL; Boccaccio, C; Charlotte, F; Gabarre, J; Gentilini, M; Gonzalez, H; Jouan, M; Leblond, V; Sutton, L | 1 |
| Barbui, T; Bertini, M; Botto, B; Cinieri, S; Cortellazzo, S; Falda, M; Freilone, R; Grignani, F; Levis, A; Liberati, AM; Locatelli, F; Lovisone, E; Marmont, F; Pizzuti, M; Resegotti, L; Rossi, A; Viero, P; Vitolo, U | 1 |
| Aydemir, U; Bierwolf, S; Brittinger, G; Engelhard, M; Gerhartz, HH; Griesser, H; Huhn, D; Lennert, K; Meusers, P; Siegert, W; Thiel, E; Tiemann, M; Wilmanns, W | 1 |
| Hizawa, Y; Itoh, J; Kawamura, S; Munakata, A; Nakui, Y; Saitoh, S; Satoh, T; Taka-mi, H; Tamura, Y; Tsushima, K | 1 |
| Aller, P; De Blas, E; Galan, A; Garcia-Bermejo, L; Perez, C; Vilaboa, NE | 1 |
| Barbui, T; Bellavita, P; Cortelazzo, S; Marchioli, R; Marfisi, RM; Rambaldi, A; Rossi, A; Viero, P | 1 |
| Fazeny, B; Fridrik, MA; Greil, R; Hausmaninger, H; Helm, W; Hudec, M; Klocker, J; Krieger, O; Neubauer, M; Oppitz, P; Pont, J; Radaszkiewicz, T; Simonitsch, I; Stöger, M | 1 |
| Connors, JM; Gascoyne, RD; Hoskins, PJ; Klasa, R; Le, N; O'Reilly, S; Shenkier, T | 1 |
| Amin, K; Anderlini, P; Andersson, B; Cabanillas, F; Champlin, R; Claxton, D; de Lima, M; Donato, M; Gajewski, J; Giralt, S; Khouri, I; Mehra, R; Popat, U; Preti, A; Przepiork, D; Pugh, W; Rodriguez, A; Rodriguez, J; Romaguera, J; van Besien, K | 1 |
| Goto, S; Kumagai, K; Nakaseko, C; Sakai, C; Takagi, T | 1 |
| Alcalá, A; Alvarez-Carmona, AM; Besses, C; Carbonell, F; Contreras, E; Fontanillas, M; García-Conde, J; Hernando, A; León, P; López-Guillermo, A; Maldonado, J; Montserrat, E; Sancho-Tello, R; Zubizarreta, A | 1 |
| Bloor, AJ; Marcus, RE; Seale, JR | 1 |
| Gulati, SC; Jhanwar-Uniyal, M | 1 |
| Centurioni, R; Chisesi, T; Congiu, AM; Contu, A; De Souza, C; Guarnaccia, C; Leoni, P; Majolino, I; Mangoni, L; Nati, S; Olivieri, A; Pescosta, N; Porcellini, A; Rizzoli, V; Rossi, E; Rubagotti, A; Salvagno, L; Santini, G; Sertoli, MR; Soracco, M; Spriano, M; Tedeschi, L; Vespignani, M; Vimercati, R; Zambaldi, G | 1 |
| Astori, C; Bernasconi, C; Bernasconi, P; Lazzarino, M; Orlandi, E | 1 |
| Arguiñano, JM; Gorosquieta, AM; Pérez Equiza, E | 1 |
| Hirayama, A; Kadota, T; Maeda, N; Nakagawa, H; Tsuzuki, T; Yamamoto, H | 1 |
| Anami, K; Asami, K; Chin, M; Fujimoto, T; Hatae, Y; Hirota, T; Horikoshi, Y; Ito, M; Iwai, A; Kaneko, Y; Katano, N; Kataoka, S; Kikuchi, M; Koizumi, S; Miyawaki, T; Mugisima, H; Nakayama, M; Nishikawa, K; Osima, K; Suzumiya, J; Taga, T; Tanaka, A; Tsurusawa, M; Watanabe, A; Yanase, T | 1 |
| Dommann-Scherrer, C; Glanzmann, C; Honegger, H; Jacky, E; Jost, LM; Kroner, T; Marincek, B; Maurer, R; Pestalozzi, B; Pichert, G; Sauter, C; Stahel, RA | 1 |
| Alvarez Román, MT; Canales Albendea, MA; del Pozo Pozo, I; Hernández Navarro, F | 1 |
| Bonadonna, G; Ferreri, AJ; Giardini, R; Rampinelli, I; Siracusano, L; Tondini, C; Valagussa, P | 1 |
| Ali, NM; Darwish, T; Elattar, I; Gaafar, R; Khaled, HM; Moawad, MS; Mokhtar, N; Zekri, ZK | 1 |
| Cunningham, DC; Gregory, WM; Hancock, BW; Hoskin, PJ; Linch, DC; Maclennan, KA; Milligan, D; Newland, AC; Smith, P; Stevenson, PA; Vaughan, B; Vaughan, G; Wood, JK | 1 |
| Bourhis, JH; Brault, P; Fenaux, P; Koscielny, S; Munck, JN; Pico, J; Ribrag, V; Vantelon, JM | 1 |
| Balaguer-Martínez, JV; Castillo-Pallarés, FJ; Mateo-Navarro, A; Rodilla Sala, E; Ruíz-Hernández, G; Solano-Vercet, C; Terol-Castera, MJ | 1 |
| Chizzali-Bonfadin, C; Filipits, M; Heinzl, H; Jaeger, U; Pirker, R; Simonitsch, I | 1 |
| Hirata, M; Kanda, M; Kikuchi, M; Kumagawa, M; Nagano, M; Nawa, Y; Ohshima, K; Suzumiya, J; Tamura, K | 1 |
| Kirov, I; Lones, MA; Neudorf, S; Said, JW; Shintaku, IP | 1 |
| Fujimori, Y; Itoh, T; Kakishita, E; Mori, A; Nishimura, Y; Okada, M; Okamoto, T; Saheki, K; Takatsuka, H; Tamura, A; Wada, H; Yamada, S | 1 |
| Achour, E; Azar, N; Belanger, C; Cassoux, N; Delattre, JY; Gerber, S; Hoang-Xuan, K; Leblond, V; Levy, V; Ribrag, V; Soussain, C; Suzan, F | 1 |
| Balaguer-Martínez, JV; Castillo-Pallarés, FJ; Ferrer Albiach, C; Pallardó-Calatayud, J; Romero-de-Avila, C; Ruiz Hernández, G | 1 |
| Douglas, R; Michael, B; Nabil, S; Thomas, F | 1 |
| Bartlett, NL; Canellos, GP; Gockerman, JP; Johnson, JL; Omura, GA; Parker, BA; Peterson, BA; Petroni, GR; Robert, M; Wagner, ND | 1 |
| Angus, B; Carey, PJ; Conn, J; Culligan, D; Haynes, A; Iqbal, A; Jackson, GH; Lennard, AL; Leonard, RC; Lucraft, H; Proctor, SJ; Russel, N; Stark, A; Taylor, PR; Wood, K | 1 |
| Andresen, S; Bolwell, B; Goormastic, M; Kalaycio, M; Kuczkowski, E; McBee, M; Pohlman, B; Sobecks, R; Wise, K | 1 |
| Bertè, R; Cavanna, L; Civardi, G; Lazzaro, A; Moroni, CF; Vallisa, D | 1 |
| Akiba, M; Bessho, M; Hirashima, K; Itoh, K; Itoh, Y; Kashimura, T; Kawai, N; Kishimoto, K; Matsuda, A; Murohashi, I; Sakata, T; Suzuki, T; Takahashi, T; Tominaga, K; Wakao, D; Yagasaki, F; Yoshida, K | 1 |
| Bernis, C; de La Cámara, R; Osorio, S | 1 |
| Ariatti, C; Bertini, M; Boccomini, C; Botto, B; Calvi, R; Capello, D; Carbone, A; Freilone, R; Gaidano, G; Gallo, E; Gloghini, A; Milan, I; Novero, D; Orsucci, L; Palestro, G; Parvis, G; Pregno, P; Saglio, G; Vitolo, U; Vivenza, D; Zagonel, V | 1 |
| Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
| Ho, AD; Kornacker, M; Kraemer, A; Leo, E | 1 |
| Balis, F; Chabner, BA; Cheson, BD; Cole, D; Drbohlav, N; Grossbard, ML; Gutierrez, M; Harris, N; Jaffe, ES; Janik, J; Little, RF; Longo, DL; Pearson, D; Pittaluga, S; Raffeld, M; Staudt, L; Steinberg, SM; Wilson, WH; Wittes, R | 1 |
| Barbarano, L; Cairoli, R; Gargantini, L; Grillo, G; Marenco, P; Morra, E; Nosari, AM; Tedeschi, A; Tresoldi, E | 1 |
| Broxson, EH; Dole, MG; Dunkel, IJ; Filippa, DA; George, D; Heath, JA; Lyden, D | 1 |
| Antoniolli, SZ; Curti, P; D'Amico, A; Ficarra, V; Malossini, G; Martignoni, G; Matteo, B; Novella, G; Porcaro, AB | 1 |
| Amiel, JL; Hayat, M; Mathé, G; Pouillart, P; Schwarzenberg, L; Tubiana, M | 1 |
| Higuchi, S; Itoh, T; Kishibe, T; Sakata, Y; Seino, Y; Sohma, N; Sugimoto, N; Suzuki, H | 1 |
| Fujita, T; Ito, M; Matsui, T; Nakao, Y; Natazuka, T; Sugimoto, T | 1 |
| Chisa, M; Hasegawa, S; Katoh, M; Koike, M; Kubomatsu, Y; Kunika, N; Nakamura, K; Sano, F; Takahashi, M; Wakayama, T | 1 |
| Bakels, V; Beljaards, RC; Huijgens, PC; Rijlaarsdam, JU; Willemze, R | 1 |
| Itatani, H; Itoh, H; Takatera, H; Tsujimura, T; Utsunomiya, M | 1 |
| Chabner, BA | 1 |
| Battifora, H; Moncada, A; Purdy, LJ; Sheibani, K; Stroup, RM | 1 |
| Connors, JM; Klimo, P; O'Reilly, SE | 1 |
| Connors, JM; Hoskins, P; Klimo, P; O'Reilly, SE | 1 |
| Alavi, A; Fox, K; Silfen, D | 1 |
| Cartwright, KC; Duncan, MH; Foucar, E; McConnell, TS; Winter, SS | 1 |
| Kanda, C; Matsubara, T; Matsumoto, T; Miyaoka, K | 1 |
| Close, P; Meister, L; Ruchelli, E | 1 |
| Boiocchi, M; D'Incalci, M; Erba, E; Lorico, A; Rappa, G; Sen, S | 1 |
| Debranin, CO | 1 |
| Alleman, MJ; Peters, WG; Schaafsma, MR; Tham, RT; Willemze, R | 1 |
| Farmer, ER; Friedman, KJ; Hood, AF; Yokel, BK | 1 |
32 review(s) available for etoposide and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
DA-R-EPOCH vs R-CHOP in DLBCL: How do we choose?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2021 |
DA-EPOCH-R improves the prognosis of patients with double-expressor lymphoma: A single-center retrospective study and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vincristine | 2022 |
Quantitative evaluation of therapy options for relapsed/refractory diffuse large B-cell lymphoma: A model-based meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Rituximab; Transplantation, Autologous | 2023 |
Adrenal diffuse large B-cell lymphoma with high PD-L1 expression: Two case reports and literature review.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Biomarkers, Tumor; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 2020 |
Perspectives on chemotherapy for the management of double-hit lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Molecular Targeted Therapy; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Recurrence; Secondary Prevention; Treatment Outcome; Vincristine | 2020 |
The Spectrum of MYC Alterations in Diffuse Large B-Cell Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cyclophosphamide; Doxorubicin; Etoposide; Gene Dosage; Humans; Lymphoma, Large B-Cell, Diffuse; Mutation; Prednisolone; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Rituximab; Vincristine | 2020 |
Diffuse Large B-cell Lymphoma of Testis: a Case Report and Current Literature Review.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Orchiectomy; Prednisolone; Testicular Neoplasms; Vincristine | 2020 |
Autologous Stem Cell Transplantation in the Management of Relapsed Non-Hodgkin Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials, Phase III as Topic; Cyclophosphamide; Cytarabine; Etoposide; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Randomized Controlled Trials as Topic; Recurrence; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous | 2021 |
Double-Hit Large B Cell Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Rearrangement; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mutation; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Vincristine | 2017 |
Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing Outcomes.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Plasmablastic Lymphoma; Prednisone; Rituximab; Vincristine | 2017 |
How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Patient Selection; Prednisone; Risk Factors; Rituximab; Vincristine | 2018 |
Venous Flare Reactions: A Case Report of Reactions Following Etoposide Infusion.
Topics: Aged; Antineoplastic Agents; Etoposide; Humans; Hypersensitivity; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Male; Oncology Nursing; Patient Safety; Risk Assessment; Vasculitis; Veins | 2018 |
[MYC-associated B-cell lymphomas: pathophysiology and treatment].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Rituximab; Vincristine | 2019 |
Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment?
Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biphenyl Compounds; Cyclophosphamide; Doxorubicin; Enhancer of Zeste Homolog 2 Protein; Etoposide; Gene Expression Profiling; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Molecular Diagnostic Techniques; Morpholines; Mutation; Prednisone; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Pyridones; Receptors, Chimeric Antigen; Risk; Rituximab; Translocation, Genetic; Vincristine | 2019 |
Outcomes after (90) Yttrium-ibritumomab tiuxetan-BEAM in diffuse large B-cell lymphoma: a meta-analysis.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chemoradiotherapy; Cytarabine; Disease-Free Survival; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Melphalan; Radiopharmaceuticals; Treatment Outcome | 2014 |
[Treatment strategy of gray zone lymphomas].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Rituximab; Vincristine | 2014 |
[Primary breast diffuse large B-cell lymphoma-report of 21 cases from China with literatures review].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; China; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vincristine | 2015 |
ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Prednisone; Radiotherapy; Rituximab; Vincristine; Vindesine | 2015 |
Contralateral testicular relapse after prophylactic radiation in a patient with primary testicular diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood-Testis Barrier; Bone Marrow; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Orchiectomy; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Testicular Neoplasms; Transplantation Conditioning; Treatment Failure; Vincristine | 2009 |
[Management of diffuse large B-cell lymphoma in the rituximab era].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2009 |
[Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Rituximab; Vincristine | 2011 |
Spontaneous gastrosplenic fistula secondary to primary splenic lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cooperative Behavior; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Fistula; Gastric Fistula; Humans; Ifosfamide; Image Interpretation, Computer-Assisted; Interdisciplinary Communication; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Multidetector Computed Tomography; Patient Care Team; Radiographic Image Enhancement; Rituximab; Spleen; Splenic Diseases; Splenic Neoplasms; Vincristine | 2010 |
Is there any role for transplantation in the rituximab era for diffuse large B-cell lymphoma?
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Therapy; Etoposide; Gene Expression Profiling; Humans; Idarubicin; Lymphoma, Large B-Cell, Diffuse; Medical Oncology; Prognosis; Recurrence; Rituximab; Salvage Therapy; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2012 |
[Therapy-related acute myeloid leukemia following double autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Monocytic, Acute; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Second Primary | 2002 |
[Primary cardiac lymphoma: cytological diagnosis and treatment with response to polychemotherapy and hematopoietic precursor autotransplant. Presentation of a case a review of the literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Atrial Flutter; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Echocardiography, Transesophageal; Etoposide; Heart Failure; Heart Neoplasms; Heart Septum; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Immunocompetence; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Melphalan; Methotrexate; Middle Aged; Pleural Effusion; Prednisone; Remission Induction; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 2002 |
Treatment of large cell lymphoma in elderly patients with a mitoxantrone, cyclophosphamide, etoposide, and prednisone regimen: long-term follow-up results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitoxantrone; Prednisone; Remission Induction; Survival Rate; Treatment Outcome | 2003 |
Inhibition of caspase 9 and not caspase 8 mediated apoptosis may determine clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 8; Caspase 9; Caspase Inhibitors; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Models, Biological; Risk; Signal Transduction; Treatment Outcome | 2005 |
HIV-related lymphoma treated with maintenance thalidomide.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Axilla; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunotherapy; Lymphatic Irradiation; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Thalidomide; Vincristine | 2005 |
Fourth biannual report of the Cochrane Haematological Malignancies Group.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Europe; Hematologic Neoplasms; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Meta-Analysis as Topic; Multicenter Studies as Topic; Multiple Myeloma; National Institutes of Health (U.S.); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Pyrazines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Transplantation, Autologous; United States; Vinblastine; Vincristine | 2006 |
[ALK-negative primary gastric anaplastic large cell lymphoma].
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Remission Induction; Salvage Therapy; Stomach Neoplasms; Transplantation, Autologous | 2007 |
Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cisplatin; Colonic Diseases; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Doxorubicin; Duodenal Ulcer; Epstein-Barr Virus Infections; Etoposide; Gastrointestinal Hemorrhage; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Neuroblastoma; Orbital Neoplasms; Prion Diseases; Transplantation Conditioning; Transplantation, Autologous; Ulcer; Vincristine | 2000 |
Primary lymphoma of the kidney. Report of a case and update of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunophenotyping; Kidney; Kidney Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Nephrectomy; Prednisone; Vincristine | 2002 |
98 trial(s) available for etoposide and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Dose-Adjusted Etoposide, Doxorubicin, and Cyclophosphamide With Vincristine and Prednisone Plus Rituximab Therapy in Children and Adolescents With Primary Mediastinal B-Cell Lymphoma: A Multicenter Phase II Trial.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Prednisone; Prognosis; Prospective Studies; Rituximab; Vincristine | 2021 |
Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; Sulfonamides; Vincristine | 2022 |
No Evident Prognostic Benefit of Statin Use in Diffuse Large B-Cell Lymphoma Patients with Unfavorable Disease Features Treated with R-DA-EPOCH.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prognosis; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2022 |
Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Prednisone; Vinblastine; Vincristine | 2023 |
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Prospective Studies; Rituximab | 2023 |
Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prospective Studies; Rituximab; Vincristine | 2023 |
Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial.
Topics: Adolescent; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Rituximab; Young Adult | 2023 |
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Vincristine | 2023 |
Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Prospective Studies; Proteasome Endopeptidase Complex; Rituximab | 2023 |
Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Autografts; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Prednisone; Rituximab; Survival Rate; Vincristine | 2020 |
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Prospective Studies; Rituximab; Vincristine | 2021 |
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Progression-Free Survival; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Rituximab; Vincristine; Young Adult | 2020 |
Dose-adjusted EPOCH-R in patients with newly diagnosed diffuse large B-cell lymphoma harboring MYC rearrangement.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Gene Rearrangement; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisone; Prospective Studies; Proto-Oncogene Proteins c-myc; Rituximab; Vincristine | 2020 |
Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Comorbidity; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Rituximab; Survival Rate | 2020 |
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Rituximab; Vincristine | 2020 |
Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma.
Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Piperidines; Prednisone; Treatment Outcome; Vincristine | 2021 |
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Germany; Germinal Center; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Rituximab; Survival Rate; Translocation, Genetic; Vincristine; Young Adult | 2017 |
Adjuvant everolimus in high-risk diffuse large B-cell lymphoma: final results from the PILLAR-2 randomized phase III trial.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Everolimus; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Rituximab; Vincristine; Young Adult | 2018 |
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL.
Topics: Adenine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Piperidines; Pyrazoles; Pyrimidines; Remission Induction; Rituximab | 2018 |
Reduced-dose EPOCH-R chemotherapy for elderly patients with advanced stage diffuse large B cell lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Staging; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine | 2018 |
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gene Rearrangement; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Proto-Oncogene Proteins c-myc; Rituximab; Treatment Outcome; Vincristine | 2018 |
Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisolone; Retrospective Studies; Risk Factors; Rituximab; Survival Rate; Vincristine | 2019 |
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Maintenance Chemotherapy; Male; Maximum Tolerated Dose; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Rituximab; Translocation, Genetic; Treatment Outcome; Vincristine | 2019 |
High-dose etoposide could discriminate the benefit from autologous peripheral blood stem cell transplantation in the patients with refractory diffuse large B cell lymphoma.
Topics: Adolescent; Adult; Autografts; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Rituximab; Survival Rate | 2019 |
Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Progression-Free Survival; Prospective Studies; Radiotherapy Dosage; Rituximab; Vincristine | 2019 |
Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Progression-Free Survival; Vincristine; Young Adult | 2019 |
Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; France; Humans; Ifosfamide; Infant; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Prospective Studies; Recurrence; Rituximab; Survival Rate | 2019 |
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT C
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Melphalan; Middle Aged; Prospective Studies; Radioimmunotherapy; Recurrence; Rituximab; Transplantation, Autologous; Young Adult | 2013 |
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Recombinant Proteins; Retrospective Studies; Rituximab; Stroke Volume; Vincristine; Young Adult | 2013 |
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prognosis; Recurrence; Rituximab; Salvage Therapy; Thalidomide; Treatment Outcome | 2014 |
Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Rituximab; Transplantation, Autologous; Treatment Outcome; Vincristine | 2014 |
Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Autografts; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Hydroxamic Acids; Lymphoma, Large B-Cell, Diffuse; Male; Maximum Tolerated Dose; Palliative Care; Prednisolone; Recurrence; Rituximab; Stem Cell Transplantation; Survival Rate; Vorinostat | 2015 |
Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2015 |
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placeb
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cough; Cyclophosphamide; Double-Blind Method; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome; Vincristine | 2015 |
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404).
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prospective Studies; Rituximab; Vincristine; Young Adult | 2015 |
Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Deoxycytidine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Salvage Therapy; Survival Analysis; Time Factors; Transplantation, Autologous | 2015 |
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Salvage Therapy; Thalidomide; Treatment Outcome; Young Adult | 2016 |
Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Rituximab; Transplantation, Autologous; Treatment Outcome; Vincristine | 2016 |
[Clinical Efficacy Comparison of Different Second Line Salvage Chemotherapy Regimens for the Treatment of Elderly Patients with Relapsed and Refractory Diffuse Large B Cell Lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Prognosis; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome | 2016 |
Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunophenotyping; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Monitoring, Physiologic; Prednisolone; Prednisone; Prognosis; Protein Array Analysis; Proteomics; Risk Factors; Rituximab; Survival Analysis; Vincristine; Young Adult | 2016 |
Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; CD5 Antigens; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Proteins; Prednisone; Rituximab; Survival Rate; Vincristine | 2017 |
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Positron-Emission Tomography; Prednisone; Retreatment; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2017 |
Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Vincristine | 2008 |
Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Deoxycytidine; Dexamethasone; Etoposide; Female; Follow-Up Studies; Gemcitabine; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Stem Cell Transplantation; Treatment Outcome; Young Adult | 2009 |
[A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma].
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fever; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Prospective Studies; Remission Induction; Rituximab; Survival Rate; Vincristine; Vomiting; Young Adult | 2009 |
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Child; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; HIV; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Viral Load; Young Adult | 2010 |
Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Neoplasm Staging; Prednisolone; Prognosis; Recurrence; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Vincristine; Young Adult | 2010 |
Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisolone; Prognosis; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Young Adult | 2010 |
Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Australia; Carboplatin; Chemotherapy, Adjuvant; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Europe; Female; Humans; Ifosfamide; Israel; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; New York City; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Rituximab; Salvage Therapy; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Treatment Outcome; Young Adult | 2010 |
Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low-intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vindesine; Young Adult | 2010 |
Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nitrosourea Compounds; Pilot Projects; Procarbazine; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome | 2011 |
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Rituximab; Survival Rate; Vincristine; Young Adult | 2012 |
Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cisplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Proteasome Endopeptidase Complex; Pyrazines; Recurrence; Rituximab; Time Factors; Treatment Outcome | 2012 |
Bullous acral erythema: an additional consideration in the differential diagnosis of pauci-inflammatory subepidermal bullae*.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blister; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hand-Foot Syndrome; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Prednisolone; Vincristine | 2012 |
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Genes, myc; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Rituximab; Salvage Therapy; Transplantation, Autologous; Treatment Failure; Young Adult | 2012 |
Two-weekly dose-adjusted (DA)-EPOCH-like chemotherapy with high-dose dexamethasone plus rituximab (DA-EDOCH14-R) in poor-prognostic untreated diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prospective Studies; Rituximab; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2013 |
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Rituximab; Vincristine; Young Adult | 2013 |
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Risk Factors; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2003 |
Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Prednisone; Recombinant Proteins; Survival Rate; Vincristine | 2003 |
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome; Vincristine | 2004 |
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neutropenia; Remission Induction; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous | 2004 |
Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2004 |
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease Progression; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Leukapheresis; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Scandinavian and Nordic Countries; Treatment Outcome | 2004 |
Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Caspase 8; Caspase 9; Caspases; Etoposide; Female; Humans; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Poly(ADP-ribose) Polymerases; Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Treatment Outcome; X-Linked Inhibitor of Apoptosis Protein | 2005 |
Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Radiotherapy Dosage; Recurrence; Survival Rate | 2005 |
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Salvage Therapy; Survival Rate; Vincristine | 2005 |
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 2006 |
Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cisplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2006 |
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Rituximab; Survival Analysis; Transplantation, Autologous; Vincristine | 2006 |
Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Quality of Life; Survival Rate; Time Factors; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bleomycin; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Count; Cyclophosphamide; Doxorubicin; Etoposide; Female; Flow Cytometry; Humans; Immunophenotyping; Kaplan-Meier Estimate; Killer Cells, Natural; Lymphoma, Large B-Cell, Diffuse; Lymphopenia; Male; Middle Aged; Monocytes; Peripheral Blood Stem Cell Transplantation; Rituximab; Treatment Outcome; Vincristine | 2007 |
VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderly.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitoxantrone; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Prognosis; Prospective Studies; Risk Assessment; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Vincristine | 2008 |
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxorubicin; Etoposide; Germinal Center; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisone; Prognosis; Rituximab; Vincristine | 2008 |
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Eye Neoplasms; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Survival Rate; Thiotepa | 2008 |
[CAMBO-VIP for advanced diffuse large cell lymphoma (LSG classification)--a long-term follow-up study].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Liver; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Vincristine | 1994 |
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vincristine | 1994 |
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors | 1995 |
In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Probability; Prognosis; Prospective Studies; Treatment Outcome; Vincristine | 1993 |
Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Foot Diseases; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Pain; Peripheral Nervous System Diseases; Vincristine | 1996 |
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Survival Analysis; Vincristine | 1996 |
PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Male; Mechlorethamine; Methotrexate; Middle Aged; Neurologic Examination; Prednisone; Procarbazine; Steroids; Survival Analysis; Vincristine | 1996 |
Peripheral blood T cell subsets as prognostic indicators of chemotherapy outcome in AIDS patients with large cell lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Didanosine; Doxorubicin; Etoposide; Humans; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; T-Lymphocyte Subsets; Treatment Outcome; Vincristine | 1996 |
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas.
Topics: Adult; Aged; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cell Division; Cyclophosphamide; Cytarabine; Dexamethasone; DNA, Neoplasm; Doxorubicin; Etoposide; Female; Flow Cytometry; Humans; Leucovorin; Life Tables; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1997 |
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphocyte Count; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neutropenia; Prednisolone; Recombinant Proteins; Vincristine | 1997 |
[Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hem
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Data Interpretation, Statistical; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Survival Analysis; Time Factors; Vincristine | 1998 |
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Salvage Therapy; Survival Rate; Vincristine | 1998 |
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine | 1998 |
A randomized EPOCH vs. CHOP front-line therapy for aggressive non-Hodgkin's lymphoma patients: long-term results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Analysis; Vincristine | 1999 |
A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Invasiveness; Prednisolone; Severity of Illness Index; Survival Analysis; United Kingdom; Vincristine | 2000 |
Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Models, Theoretical; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors | 2000 |
Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Eye Neoplasms; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Salvage Therapy; Thiotepa | 2001 |
Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Treatment Outcome; Vincristine | 2001 |
High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Salvage Therapy; Survival Rate; Treatment Outcome | 2001 |
Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisone; Recurrence; Survival Rate; Time Factors; Vincristine | 2002 |
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Monitoring; Etoposide; Female; Humans; Longitudinal Studies; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Platelet Count; Prednisone; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vincristine | 2002 |
Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Staging; Prednisone; Survival Analysis; Vincristine | 1991 |
277 other study(ies) available for etoposide and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Dose-adjusted EPOCH-rituximab or intensified B-NHL therapy for pediatric primary mediastinal large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Vincristine | 2021 |
Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Prednisone; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2021 |
Very Early Onset of Therapy-Related Acute Myeloid Leukemia with 11q23 Rearrangement Presenting with Unusual PET Findings after R-DA-EPOCH for Primary Mediastinal Large B-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Prednisone; Vincristine | 2021 |
Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteria.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Mitoxantrone; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisolone; Prognosis; Retrospective Studies; Rituximab; Vincristine | 2021 |
Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B-Cell lymphoma -results of a single center, retrospective cohort in China.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Etoposide; Frail Elderly; Histone Deacetylase Inhibitors; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Retrospective Studies; Rituximab | 2022 |
Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prospective Studies; Rituximab; Vincristine; Young Adult | 2022 |
Burden of Illness and Treatment Patterns in Second-line Large B-cell Lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cost of Illness; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Medicare; Prednisone; Rituximab; United States; Vincristine | 2022 |
Successful multidisciplinary management of an asymptomatic gastrosplenic fistula in a diffuse large B cell lymphoma patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fistula; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Rituximab; Splenectomy; Vincristine | 2022 |
Dose-adjusted EPOCH-R is a safe and well tolerated outpatient treatment regimen in double-hit lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Outpatients; Prednisone; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2023 |
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Rituximab; Salvage Therapy | 2022 |
Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Vincristine | 2022 |
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Latin America; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Registries; Retrospective Studies; Rituximab; Vincristine | 2022 |
[A comparison of R-CHOP and R-DA-EPOCH as a first-line regimen treatment of diffuse large B cell lymphoma with non-GCB subtypes: a retrospective study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prognosis; Retrospective Studies; Rituximab; Vincristine | 2022 |
"Diffuse Large B-Cell Lymphoma in the Elderly: Real-World Outcomes From a Developing Country".
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Developing Countries; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisolone; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2022 |
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hematologic Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2022 |
A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prospective Studies; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2023 |
Dose-adjusted EPOCH-R vs. R-CHOP in frontline management of Waldeyer's ring diffuse large B-cell lymphoma: a retrospective study from a single institution.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2023 |
Dose-adjusted EPOCH and rituximab (DA-EPOCH-R) in older patients with high-risk aggressive diffuse large B-cell lymphoma: A real-life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Croatia; Cyclophosphamide; Doxorubicin; Etoposide; Hematologic Diseases; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisone; Rituximab; Vincristine | 2023 |
Real-world efficacy of DA-EPOCH-R/HD-MTX regimen in CD5-positive diffuse large B cell lymphoma: a single-institute analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2023 |
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Treatment Outcome; Vincristine | 2023 |
Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Turkey; Vincristine; Young Adult | 2023 |
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.
Topics: Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lactate Dehydrogenases; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Retrospective Studies; Rituximab; Vincristine | 2023 |
PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Programmed Cell Death 1 Receptor; Retrospective Studies; Rituximab | 2023 |
Efficacy of ESHAP versus ICE plus dexamethasone (DICE) as salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
Topics: Cisplatin; Cytarabine; Dexamethasone; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Methylprednisolone; Retrospective Studies | 2023 |
Retrospective Analysis of 20 Patients with DLBCL Who Received MCVAC Followed by Autologous Peripheral Blood Stem Cell Transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2019 |
Reply to T.M. Weis et al.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Vincristine | 2019 |
Dosing Vincristine in Dose-Adjusted EPOCH-R: To Cap or Not to Cap?
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Vincristine | 2019 |
Chimeric antigen receptor T-cell therapy's role in antiphospholipid syndrome: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Antiphospholipid Syndrome; Cyclophosphamide; Doxorubicin; Etoposide; Facial Neoplasms; Female; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Vincristine | 2020 |
Epstein-Barr virus-positive diffuse large B cell lymphoma, not otherwise specified, carrying a t(19;22)(q13;q11) translocation.
Topics: Abnormal Karyotype; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Chromosomes, Human, Pair 19; Chromosomes, Human, Pair 22; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Prednisone; Rituximab; RNA, Neoplasm; RNA, Viral; Translocation, Genetic; Vincristine | 2020 |
Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Incidence; Lymphoma, Large B-Cell, Diffuse; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2020 |
Allogenic hematopoietic stem cell transplantation for prolonged bone marrow aplasia after chimeric antigen receptor (CAR) T-cell therapy for relapsed diffuse large B-cell lymphoma.
Topics: Adrenal Cortex Hormones; Allografts; Anemia, Aplastic; Antibodies, Monoclonal, Humanized; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Deoxycytidine; Doxorubicin; Etoposide; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Oxaliplatin; Prednisone; Recurrence; Rituximab; Salvage Therapy; Transplantation, Autologous; Vincristine | 2020 |
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Multivariate Analysis; Registries; Rituximab; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Failure; Treatment Outcome; Young Adult | 2020 |
[Feasibility of PEG-rhG-CSF in the first-line treatment of diffuse large B-cell lymphoma receiving dose-adjusted EPOCH plus rituximab].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Polyethylene Glycols; Prednisone; Recombinant Proteins; Rituximab; Vincristine | 2020 |
Gene rearrangements of MLL and RUNX1 sporadically occur in normal CD34
Topics: Aged; Cell Survival; Cells, Cultured; Core Binding Factor Alpha 2 Subunit; Cytokines; Etoposide; Gene Rearrangement; Hematopoietic Stem Cells; Histone-Lysine N-Methyltransferase; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Myeloid-Lymphoid Leukemia Protein; Peripheral Blood Stem Cells; Topoisomerase II Inhibitors | 2020 |
Presentation and management of primary mediastinal large B-cell lymphoma: a retrospective cohort analysis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine; Young Adult | 2020 |
Thioredoxin-1 as a biological predictive marker for selecting diffuse large B-cell lymphoma patients for etoposide-containing treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cell Line, Tumor; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Expression; Gene Knockout Techniques; Humans; Immunophenotyping; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Rituximab; Thioredoxins; Treatment Outcome; Vincristine | 2020 |
Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; MicroRNAs; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Rituximab; Transcriptome; Vincristine; Young Adult | 2020 |
Progressive dyspnea and diffuse ground-glass opacities after treatment for lymphoma with rituximab-containing chemotherapy: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Dyspnea; Etoposide; Humans; Lung Diseases, Interstitial; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prognosis; Rituximab; Vincristine | 2020 |
A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Examination; Cyclophosphamide; Doxorubicin; Etoposide; Fever; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Vincristine; Whole Body Imaging | 2021 |
Venetoclax Boosts Benefits of R-EPOCH in Aggressive B-Cell Lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Sulfonamides; Vincristine | 2020 |
Dose-adjusted EPOCH-R: a feasible alternative for Burkitt lymphoma in resource-constrained settings.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; United Kingdom; Vincristine | 2020 |
Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma.
Topics: Adenine; Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow; Bone Marrow Cells; China; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Piperidines; Prednisone; Prognosis; Rituximab; Transplantation, Autologous; Vincristine | 2020 |
Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hepatic Encephalopathy; HIV Infections; Humans; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisone; Retrospective Studies; Sepsis; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome; Uganda; Vincristine | 2020 |
R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Progression-Free Survival; Retrospective Studies; Rituximab; Steroids; Treatment Outcome; Vincristine; Young Adult | 2021 |
[Analysis of Relevant Factors of Refractory and Relapse DLBCL Treated by Rituximab Combined with CHOP/EPOCH Regimen].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Prognosis; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2020 |
Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Female; Germinal Center; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Progression-Free Survival; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Autologous | 2021 |
DECC (dexamethasone, etoposide, chlorambucil, lomustine) as an oral chemotherapy regimen in relapsed and refractory diffuse large B-cell lymphoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dexamethasone; Etoposide; Female; Humans; Lomustine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local | 2021 |
Prognostic value of lymphocyte-to-monocyte ratio and histone methyltransferase G9a histone methyltransferase in patients with double expression lymphoma: A retrospective observational study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; China; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Expression; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Kaplan-Meier Estimate; Lymphocyte Count; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Monocytes; Prednisone; Proportional Hazards Models; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Retrospective Studies; Vincristine | 2021 |
[Clinical Characteristics for Cutaneous Involvement in Diffuse Large B-Cell Lymphoma and Hemophagocytic Syndrome patients with First Presentation of Dermatomyositis].
Topics: Dermatomyositis; Etoposide; Female; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Retrospective Studies | 2021 |
Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cohort Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Inflammation; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peru; Prednisone; Prognosis; Progression-Free Survival; Retrospective Studies; Risk Factors; Rituximab; Treatment Outcome; Vincristine | 2021 |
Interim and end-of-treatment PET-CT suffers from high false-positive rates in DLBCL: Biopsy is needed prior to treatment decisions.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Clinical Decision-Making; Confidence Intervals; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; False Positive Reactions; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prednisone; Proportional Hazards Models; Rituximab; Survival Rate; Treatment Outcome; Vincristine | 2021 |
Posterior reversible encephalopathy syndrome in a patient with Richter's syndrome on combination DA-R-EPOCH chemotherapy regimen: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Posterior Leukoencephalopathy Syndrome; Prednisone; Vincristine | 2021 |
Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cisplatin; Cyclopropanes; Cytarabine; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Phosphatidylinositol 3-Kinases; Phosphodiesterase 4 Inhibitors; Pilot Projects | 2022 |
Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Retrospective Studies; Rituximab; ROC Curve; Time Factors; Tumor Burden; Vincristine | 2021 |
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Mutation; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Rituximab; Tumor Suppressor Protein p53; Vincristine | 2022 |
Successful treatment of refractory retroperitoneal Epstein-Barr virus-positive diffuse large B-cell lymphoma with secondary hemophagocytic syndrome by sequential combination regimen of PD-1 blockade and chimeric antigen receptor T cells: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Herpesvirus 4, Human; Humans; Immunocompetence; Immunotherapy, Adoptive; Ki-67 Antigen; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Programmed Cell Death 1 Receptor; Receptors, Chimeric Antigen; Vincristine; Young Adult | 2022 |
Primary Malignant Lymphoma Originating from the Chest Wall without Preceding Pleural Disease.
Topics: Aged, 80 and over; Antineoplastic Agents, Phytogenic; Dyspnea; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Paraganglioma; Radiography, Thoracic; Thoracic Wall; Tomography, X-Ray Computed | 2017 |
Bilateral sciatic nerve neurolymphomatosis: PET/CT findings.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Craniospinal Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Salvage Therapy; Sciatic Nerve; Vincristine | 2017 |
Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study.
Topics: Adolescent; Antimetabolites, Antineoplastic; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2017 |
MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Gene Rearrangement; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Prednisone; Proto-Oncogene Proteins c-myc; Rituximab; Treatment Outcome; Vincristine | 2018 |
[Clinical Efficacy of EPOCH±R Followed by DICE±R Regimen for Primary Breast Diffuse Large B-Cell Lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Treatment Outcome; Vincristine | 2017 |
Pegylated GCSF Can Be Used With First-Line da-EPOCH-R Without Compromising Dose Intensity, Safety, or Efficacy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Outcome Assessment, Health Care; Polyethylene Glycols; Prednisone; Rituximab; Vincristine; Young Adult | 2017 |
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Rituximab; Thrombosis; Treatment Outcome; Vincristine; Young Adult | 2017 |
Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Retrospective Studies; Risk Factors; Vincristine; Young Adult | 2017 |
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.
Topics: Administration, Metronomic; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Organic Chemicals; Retrospective Studies; Treatment Outcome; Vinorelbine | 2018 |
Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Gene Rearrangement; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Melphalan; Middle Aged; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Rituximab; Transplantation, Autologous; Treatment Outcome; Vincristine | 2018 |
Successful treatment of concomitant metastatic prostate cancer and B-cell non-Hodgkin's lymphoma with R-EPOCH chemotherapy regimen and antiandrogen therapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms; Rituximab; Vincristine | 2018 |
Patterns of Failure in Patients With Double Hit or Double Expressor Lymphomas: Implications for Radiation Therapy.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, myc; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Proteins; Prednisone; Prognosis; Progression-Free Survival; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Retrospective Studies; Rituximab; Treatment Failure; Vincristine; Young Adult | 2018 |
Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab.
Topics: Antigens, CD20; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Molecular Targeted Therapy; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisone; Rituximab; Vincristine | 2018 |
Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Rituximab; ROC Curve; Severity of Illness Index; Vincristine | 2018 |
DA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Phenotype; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Remission Induction; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2019 |
Hydration, methylene blue, and thiamine as a prevention regimen for ifosfamide-induced encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methylene Blue; Middle Aged; Rituximab; Thiamine | 2019 |
Pure Seminoma and Concurrent Aggressive Lymphoma: Case Report of a Patient With Persistent Müllerian Duct Syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disorder of Sex Development, 46,XY; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Staging; Neoplasms, Multiple Primary; Rituximab; Seminoma; Testicular Neoplasms; Treatment Outcome | 2019 |
Treatment of diffuse large B-cell lymphoma in elderly patients: Replacing doxorubicin with either epirubicin or etoposide (VP-16).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Substitution; Epirubicin; Etoposide; Female; Follow-Up Studies; Heart Diseases; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Matched-Pair Analysis; Prednisone; Progression-Free Survival; Retrospective Studies; Rituximab; Vincristine | 2019 |
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2019 |
Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP.
Topics: Adult; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Basic-Leucine Zipper Transcription Factors; Biomarkers, Tumor; Cell Nucleus; Cyclophosphamide; Cytoplasm; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Kelch-Like ECH-Associated Protein 1; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; NF-E2-Related Factor 1; NF-E2-Related Factor 2; Predictive Value of Tests; Prednisolone; Retrospective Studies; Risk Assessment; Risk Factors; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2019 |
Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prospective Studies; Rituximab; Standard of Care; Vincristine | 2019 |
Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care - Authors' reply.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prospective Studies; Rituximab; Standard of Care; Vincristine | 2019 |
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Organic Chemicals; Prognosis; Prospective Studies; Retrospective Studies; Rituximab; Survival Rate; Vincristine | 2019 |
[Triple expressor lymphoma in a kidney transplant patient].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxorubicin; Etoposide; Genes, myc; Humans; Kidney Transplantation; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Vincristine | 2019 |
Diffuse large B cell lymphoma with chromosomal translocation t(14;19)(q32;q13) occurring in IgG4-related disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 19; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Immunoglobulin G4-Related Disease; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Rituximab; Salvage Therapy; Translocation, Genetic | 2019 |
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2019 |
CD5 expression correlates with inferior survival and enhances the negative effect of p53 overexpression in diffuse large B-cell lymphoma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CD5 Antigens; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Proteins; Prednisone; Prognosis; Progression-Free Survival; Proportional Hazards Models; Risk Factors; Rituximab; Tumor Suppressor Protein p53; Up-Regulation; Vincristine; Young Adult | 2019 |
Update: NCCN non-Hodgkin's lymphoma clinical practice guidelines.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Practice Guidelines as Topic; Prednisone; Prognosis; Radioimmunotherapy; Rituximab; Vincristine | 2004 |
c-FLIP does not correlate with response to immunochemotherapy treatment and outcome of patients with nodal diffuse large B-cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prognosis; Rituximab; Sentinel Lymph Node Biopsy; Survival; Treatment Outcome; Vincristine; Young Adult | 2013 |
Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Young Adult | 2013 |
Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Prednisolone; Prednisone; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Failure; Vincristine | 2013 |
Long-term survival of diffuse large B cell lymphoma of the trigeminal region extending to the Meckel's cave treated by CHASER therapy: case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Nerve Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Rituximab; Survivors; Trigeminal Nerve Diseases | 2014 |
Busulfan-containing conditioning regimens are optimal preparative regimens for autologous stem cell transplant in patients with diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Busulfan; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2014 |
Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2014 |
High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Nitrosourea Compounds; Recurrence; Retrospective Studies; Survival Analysis; Transplantation, Autologous | 2014 |
Pegfilgrastim-induced pain in patients with lymphoma.
Topics: Acute Pain; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neutropenia; Oncology Nursing; Polyethylene Glycols; Prednisone; Recombinant Proteins; Rituximab; Vincristine | 2014 |
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Retrospective Studies; Rituximab; Salvage Therapy; Tomography, X-Ray Computed; Vincristine; Young Adult | 2014 |
R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Cisplatin; Cytarabine; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polyethylene Glycols; Recombinant Proteins; Recurrence; Retrospective Studies | 2014 |
[Long-term follow-up for 39 newly diagnosed diffused large B-cell lymphoma patients treated by (R)-EPOCH].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Vincristine; Young Adult | 2014 |
Epstein-Barr virus-associated diffuse large B-cell lymphoma arising in atrial myxoma: a proposal for a modified therapeutic approach.
Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Etoposide; Fatal Outcome; Heart Atria; Heart Neoplasms; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Immunohistochemistry; Interferon Regulatory Factors; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Myxoma; Prednisone; Rituximab; Vincristine; Viral Proteins | 2015 |
A unique case of refractory primary mediastinal B-cell lymphoma with JAK3 mutation and the role for targeted therapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 3; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Molecular Targeted Therapy; Mutation; Piperidines; Prednisone; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction; Stem Cell Transplantation; Transplantation, Homologous; Vincristine | 2014 |
Anaplastic lymphoma kinase-positive large B-cell lymphoma: description of a case with an unexpected clinical outcome.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Receptor Protein-Tyrosine Kinases; Remission Induction; Treatment Outcome; Vincristine | 2015 |
Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2014 |
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematologic Neoplasms; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Melphalan; Nitriles; Nitrogen Mustard Compounds; Prednisone; Primary Myelofibrosis; Pyrazines; Pyrazoles; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2014 |
UGT1A1 *6 polymorphism predicts outcome in elderly patients with relapsed or refractory diffuse large B-cell lymphoma treated with carboplatin, dexamethasone, etoposide and irinotecan.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Dexamethasone; Etoposide; Female; Follow-Up Studies; Glucuronosyltransferase; Humans; Irinotecan; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Recurrence; Treatment Outcome | 2015 |
A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma.
Topics: Acute Kidney Injury; Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Risk Assessment; Rituximab; Survival Rate; Vincristine; Young Adult | 2014 |
[Prognostic impact of anthracyclines in the treatment of aggressive lymphoma in patients over 70 years].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Prognosis; Proportional Hazards Models; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2015 |
Cell of origin predicts outcome to treatment with etoposide-containing chemotherapy in young patients with high-risk diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cell Lineage; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Germinal Center; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Rituximab; Survival Rate; Vincristine | 2015 |
The impact of age on survival of diffuse large B-cell lymphoma - a population-based study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisone; Registries; Retrospective Studies; Risk Factors; Rituximab; Survival Rate; Sweden; Vincristine; Young Adult | 2015 |
Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Boronic Acids; Bortezomib; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Positron-Emission Tomography; Prednisone; Pyrazines; Treatment Outcome; Vincristine | 2015 |
A rare case of primary high-grade large B-cell lymphoma of the sciatic nerve.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Methotrexate; Multimodal Imaging; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Prednisone; Rituximab; Sciatic Nerve; Tomography, X-Ray Computed; Vincristine | 2015 |
Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cause of Death; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Proportional Hazards Models; Radiotherapy Dosage; Rituximab; Treatment Failure; Tumor Burden; Vincristine; Young Adult | 2015 |
Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; L-Lactate Dehydrogenase; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multimodal Imaging; Population Surveillance; Positron-Emission Tomography; Prednisone; Recurrence; Retrospective Studies; Rituximab; Salvage Therapy; Tomography, X-Ray Computed; Vincristine | 2015 |
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; Rituximab; Salvage Therapy; Vincristine; Young Adult | 2015 |
Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Prednisone; Recurrence; Regression Analysis; Risk; Rituximab; Treatment Failure; Tumor Burden; Vincristine; Young Adult | 2015 |
Lack of topoisomerase copy number changes in patients with de novo and relapsed diffuse large B-cell lymphoma.
Topics: Aneuploidy; Antibodies, Monoclonal, Murine-Derived; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 20; Cyclophosphamide; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Etoposide; Gene Dosage; Humans; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Neoplasm Proteins; Poly-ADP-Ribose Binding Proteins; Prednisolone; Prednisone; Recurrence; Rituximab; Topoisomerase II Inhibitors; Vincristine | 2015 |
Diffuse large B-cell lymphoma causing acute liver failure: a rare case of survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Liver Failure, Acute; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Invasiveness; Prednisone; Treatment Outcome; Vincristine | 2015 |
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinum; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Retrospective Studies; Rituximab; Survival Analysis; Vincristine | 2015 |
Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cytarabine; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Recurrence; Retrospective Studies; Risk; Rituximab; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2015 |
A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Prognosis; Radiotherapy; Retrospective Studies; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Young Adult | 2016 |
A Demyelinating Disease; What Lies Beneath?
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Demyelinating Diseases; Diagnosis, Differential; Doxorubicin; Encephalomyelitis, Acute Disseminated; Etoposide; Humans; Hydrocortisone; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Methotrexate; Prednisone; Vincristine | 2016 |
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Herpesvirus 4, Human; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 2015 |
Impact on survival of addition of etoposide to primary chemotherapy in diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisolone; Prednisone; Registries; Rituximab; Vincristine | 2017 |
[Malignant lymphoma complicated with posterior reversible encephalopathy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Middle Aged; Posterior Leukoencephalopathy Syndrome; Rituximab | 2015 |
Bilateral psoas muscle lymphoma: an unusual presentation of EBV-positive diffuse large B-cell lymphoma of the elderly.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Muscle Neoplasms; Prednisone; Psoas Muscles; Radiography; Rituximab; Vincristine | 2015 |
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Cytarabine; Databases, Factual; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Germinal Center; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Survival Rate; Vincristine | 2016 |
Diagnosis of Giant Cell Arteritis in an Asymptomatic Patient.
Topics: Aftercare; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Asymptomatic Diseases; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Fractures, Spontaneous; Giant Cell Arteritis; Humans; Humeral Fractures; Incidental Findings; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Angiography; Male; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Rituximab; Subclavian Steal Syndrome; Temporal Arteries; Vincristine | 2016 |
Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL.
Topics: Aged; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc | 2015 |
Reduced-dose ICE chemotherapy ± rituximab is a safe and effective salvage therapy for fit elderly patients with diffuse large B-cell lymphoma.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Comorbidity; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Staging; Retrospective Studies; Rituximab; Salvage Therapy; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome | 2016 |
Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Consolidation Chemotherapy; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitoxantrone; Recurrence; Retrospective Studies; Rituximab; Stem Cell Transplantation; Treatment Outcome | 2016 |
[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Leucovorin; Logistic Models; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Multivariate Analysis; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine | 2016 |
A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ki-67 Antigen; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoadjuvant Therapy; Prednisone; Prognosis; Retrospective Studies; Rituximab; Survival Analysis; Vincristine; Young Adult | 2016 |
[Rituximab plus Autologous Hemotopoietic Stem Cell Transplantation for The Treatment of CD5 Positive Diffuse Large B Cell Lymphoma with Autoimmune Hemolytic Anemia].
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; CD5 Antigens; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Methylprednisolone; Middle Aged; Prednisone; Rituximab; Sentinel Lymph Node Biopsy; Vincristine | 2016 |
Lymphoma in Danon disease with chronic rhabdomyolysis treated with EPOCH-R: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Glycogen Storage Disease Type IIb; Heart Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Rhabdomyolysis; Rituximab; Vincristine; Young Adult | 2016 |
[Rituximab combined with EPOCH regimen for treatment of diffuse large B cell lymphoma of the gastrointestinal tract: analysis of 4 cases].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Gastrointestinal Tract; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Prognosis; Remission Induction; Rituximab; Vincristine | 2016 |
CD30 expression and prognostic significance in R-EPOCH-treated patients with diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Rearrangement; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Ki-1 Antigen; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Predictive Value of Tests; Prednisone; Proto-Oncogene Proteins c-myc; Reproducibility of Results; Rituximab; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2017 |
Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2017 |
A case report of a renal diffuse B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Vincristine | 2017 |
Sequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Cytarabine; Epstein-Barr Virus Infections; Etoposide; Gene Rearrangement; Genes, Immunoglobulin Heavy Chain; Herpesvirus 4, Human; Humans; Immunohistochemistry; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Neoplasms, Second Primary; Polymerase Chain Reaction; Prednisone; Radiotherapy, Adjuvant; Receptors, Antigen, T-Cell; Rituximab; Tomography, X-Ray Computed; Tongue | 2017 |
Probable interaction between warfarin and antitumor agents used in R-ESHAP chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Interactions; Etoposide; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Pulmonary Embolism; Venous Thrombosis; Warfarin | 2008 |
Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carmustine; Chi-Square Distribution; Cohort Studies; Cytarabine; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Length of Stay; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Mucositis; Recurrence; Risk; Statistics, Nonparametric; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2008 |
The impact of histopathologic diagnosis on the proper management of testis neoplasms.
Topics: Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Cisplatin; Cytarabine; Diagnosis, Differential; Etoposide; Fatal Outcome; Humans; Immunohistochemistry; Interferon Regulatory Factors; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Orchiectomy; Radiography; Recurrence; Remission Induction; Seminoma; Testicular Neoplasms | 2008 |
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome; Young Adult | 2008 |
Pseudo-bowel obstruction due to varicella zoster virus infection after autologous stem cell transplantation.
Topics: Acyclovir; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carmustine; Cisplatin; Colitis; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Intestinal Pseudo-Obstruction; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Postoperative Complications; Prednisolone; Rituximab; Transplantation, Autologous; Vincristine; Virus Activation | 2009 |
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Rituximab; Salvage Therapy; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Treatment Outcome | 2009 |
Effective treatment for de novo hepatitis B with nucleotide analogue in patients with hematological malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cervix Uteri; Cyclophosphamide; Doxorubicin; Etoposide; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Recurrence; Remission Induction; Stomach; Transplantation, Autologous; Vincristine | 2009 |
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Incidence; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Registries; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 2009 |
Lack of prognostic value of MMP-9 expression and immunohistochemically defined germinal center phenotype in patients with diffuse large B-cell lymphoma treated with modern chemotherapy with or without CD20 antibody.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germinal Center; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prednisolone; Prednisone; Prognosis; Rituximab; Survival Rate; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Vincristine; Young Adult | 2009 |
Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Radiotherapy, Adjuvant; Retrospective Studies; Rituximab; Survival Rate; Treatment Outcome; Vincristine; Young Adult | 2009 |
Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Lymphoma, Large B-Cell, Diffuse; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Transplantation, Autologous | 2010 |
ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cisplatin; Colony-Stimulating Factors; Cytarabine; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Remission Induction; Rituximab | 2010 |
[Tunisian experience in the treatment of aggressive non Hodgkin's lymphoma in adults: about 337 patients].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prospective Studies; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Analysis; Tunisia; Vincristine; Young Adult | 2010 |
Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisolone; Remission Induction; Sirolimus; Tongue Neoplasms; Treatment Failure; Treatment Outcome; Vincristine | 2011 |
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisolone; Retrospective Studies; Rituximab; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2010 |
LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diarrhea; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Stomatitis; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vomiting; Young Adult | 2011 |
A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Immunophenotyping; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; NM23 Nucleoside Diphosphate Kinases; Prednisolone; Prognosis; Rituximab; Vincristine; Young Adult | 2011 |
Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; DNA, Viral; Doxorubicin; Etoposide; Female; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Rituximab; Vincristine; Virus Activation | 2010 |
Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Palatine Tonsil; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Tonsillar Neoplasms; Vincristine | 2011 |
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Denmark; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Proportional Hazards Models; Registries; Retrospective Studies; Risk Factors; Rituximab; Treatment Outcome; Vincristine | 2012 |
Pretreatment serum level of 15-kDa granulysin might have a prognostic value in patients with diffuse large B cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Molecular Weight; Prednisone; Prognosis; Protein Isoforms; Recurrence; Reproducibility of Results; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Vincristine | 2011 |
Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression.
Topics: Aniline Compounds; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Survival; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; MicroRNAs; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Reverse Transcriptase Polymerase Chain Reaction; Spectral Karyotyping; Sulfonamides; Thiazoles; Translocation, Genetic | 2011 |
The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Germinal Center; Humans; Ifosfamide; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lymphoma, Large B-Cell, Diffuse; Male; Microarray Analysis; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Neoplasm Proteins; Neoplasm, Residual; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Rituximab; Salvage Therapy | 2011 |
Mini-BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCL.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Recurrence; Salvage Therapy; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Young Adult | 2012 |
Reversible, complete atrioventricular block caused by primary cardiac lymphoma in a nonimmunocompromised patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Atrioventricular Block; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Heart Neoplasms; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pacemaker, Artificial; Prednisone; Treatment Outcome; Vincristine | 2012 |
A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstei
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunophenotyping; Ki-1 Antigen; Lewis X Antigen; Lymphoma, Large B-Cell, Diffuse; Prednisone; Procarbazine; Reed-Sternberg Cells; Remission Induction; Vincristine | 2012 |
Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Salvage Therapy; Treatment Outcome; Young Adult | 2013 |
Recurrent endobronchial diffuse large B-cell lymphoma. Diagnosed by cryoprobe.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bronchi; Cisplatin; Combined Modality Therapy; Cryosurgery; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Etoposide; Humans; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Prednisone; Recurrence; Remission Induction; Rituximab; Spleen; Splenectomy; Splenomegaly; Vincristine | 2013 |
Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane; Cell Survival; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Flow Cytometry; Galectin 3; Glycosylation; Humans; Immunoblotting; Immunohistochemistry; Leukocyte Common Antigens; Lymphoma, Large B-Cell, Diffuse; N-Acetylglucosaminyltransferases; Polysaccharides; Protein Binding; Rituximab; RNA Interference; Tissue Array Analysis | 2012 |
Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cranial Nerve Neoplasms; Drug Administration Schedule; Drug Evaluation; Drug Resistance, Neoplasm; Etoposide; Eye Neoplasms; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2013 |
Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clarithromycin; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Humans; Immunophenotyping; Immunosuppressive Agents; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methotrexate; Methylprednisolone Hemisuccinate; Orbital Neoplasms; Prednisolone; Remission Induction; Rituximab; Vincristine | 2013 |
BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Prednisone; Procarbazine; Remission Induction; Rituximab; Treatment Outcome; Vincristine | 2013 |
Secondary pancreatic involvement by diffuse large B-cell lymphoma presenting as acute pancreatitis: treatment and outcome.
Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Exocrine Pancreatic Insufficiency; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Pancreatic Neoplasms; Pancreatitis; Remission Induction; Tomography, X-Ray Computed | 2002 |
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytokines; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; L-Lactate Dehydrogenase; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Podophyllotoxin; Prednisone; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2003 |
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Drug Resistance, Viral; Etoposide; Female; HIV Reverse Transcriptase; Humans; Immunohistochemistry; Leukocyte Common Antigens; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mutation; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; Survival Rate; T-Lymphocytes; Treatment Outcome; Vincristine; Viral Load | 2003 |
Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Middle Aged; Recurrence; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation Conditioning; Transplantation, Autologous | 2003 |
Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
Topics: Adolescent; Adrenal Cortex Hormones; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Cytarabine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prognosis; Sclerosis; Treatment Outcome | 2003 |
[Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 5; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Erythroblastic, Acute; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Mitoguazone; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Vinblastine; Vincristine | 2003 |
Rituximab in heavily pretreated cutaneous B-cell lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Mitoxantrone; Orchiectomy; Prednisone; Recurrence; Remission Induction; Rituximab; Skin Neoplasms; Testis; Vincristine | 2003 |
Cardiac lymphoma successfully treated with high dose chemotherapy followed by autologous haematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chest Pain; Combined Modality Therapy; Cough; Cyclophosphamide; Doxorubicin; Etoposide; Female; Heart Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Nitrosourea Compounds; Prednisolone; Procarbazine; Remission Induction; Transplantation, Autologous; Vincristine | 2003 |
Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosomes, Human; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 18; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 8; Combined Modality Therapy; Dexamethasone; DNA-Binding Proteins; Etoposide; Genes, bcl-2; Genes, myc; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogenes; Radiotherapy, Adjuvant; Remission Induction; Transcription Factors; Translocation, Genetic | 2004 |
[Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Eye Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Lymphoma, T-Cell; Middle Aged; Prognosis; Recurrence; Thiotepa | 2004 |
CD30-induced up-regulation of the inhibitor of apoptosis genes cIAP1 and cIAP2 in anaplastic large cell lymphoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Ki-1 Antigen; Lymphoma, Large B-Cell, Diffuse; Neoplasm Proteins; NF-kappa B; Protein Biosynthesis; Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Ubiquitin-Protein Ligases | 2004 |
Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Salvage Therapy; Treatment Outcome | 2004 |
Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ki-1 Antigen; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Receptors, Interleukin-2; Recurrence; Solubility; Vincristine | 2004 |
Ifosfamide, epirubicin and etoposide (IEV) regimen as salvage and mobilization therapy for refractory or early relapsing patients with aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2004 |
[Treatment of primary mediastinal large B-cell lymphomas].
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
[Successful treatment with etoposide by oral administration for recurrence of gastric diffuse large B-cell lymphoma after surgical resection--a case report].
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Etoposide; Female; Gastrectomy; Humans; Ileal Neoplasms; Liver Neoplasms; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Remission Induction; Stomach Neoplasms | 2005 |
Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital.
Topics: Acetaminophen; Acid-Base Equilibrium; Acidosis; Adult; Analgesics, Non-Narcotic; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Candidiasis; Chlorides; Cytarabine; Etoposide; Fatal Outcome; Fever; Humans; Ifosfamide; Kidney Tubular Necrosis, Acute; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Neutropenia; Polycystic Kidney, Autosomal Dominant; Pyrrolidonecarboxylic Acid; Salvage Therapy; Systemic Inflammatory Response Syndrome | 2005 |
Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic stem cell transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Remission Induction; Rituximab; Salvage Therapy; Stem Cell Transplantation; Transplantation, Homologous | 2005 |
Primary lacrimal sac non-Hodgkin's lymphoma in a child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Eye Neoplasms; Female; Humans; Hydrocortisone; Hyperplasia; Lacrimal Apparatus; Leucovorin; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Vincristine | 2005 |
Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2006 |
[Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nitrosourea Compounds; Remission Induction; Transplantation, Autologous; Treatment Outcome | 2005 |
ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cisplatin; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Peripheral Blood Stem Cell Transplantation; Recurrence; Retrospective Studies; Transplantation, Autologous | 2006 |
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Cohort Studies; Cyclin-Dependent Kinase Inhibitor p21; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Genes, p53; Germinal Center; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Proteins; Phenotype; Prednisone; Prognosis; Radiotherapy, Adjuvant; Reproducibility of Results; Rituximab; Survival Analysis; Survival Rate; Tumor Suppressor Protein p53; Vincristine | 2006 |
[A case of secondary malignant lymphoma of the urinary bladder].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Middle Aged; Mitoxantrone; Prednisone; Urinary Bladder Neoplasms; Vincristine | 2006 |
Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2006 |
Intrinsic apoptotic pathway in anaplastic large cell lymphoma.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; Cytochromes c; Disease-Free Survival; Doxorubicin; Enzyme Activation; Enzyme Inhibitors; Etoposide; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Lymphoma, Large B-Cell, Diffuse; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases | 2006 |
False-positive restaging PET scans involving the spleen in two patients with aggressive non-Hodgkin lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Carboplatin; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; False Positive Reactions; Humans; Ifosfamide; Laparoscopy; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Remission Induction; Rituximab; Salvage Therapy; Spleen; Splenectomy; Tomography, X-Ray Computed; Unnecessary Procedures; Vincristine | 2006 |
Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Male; Methylprednisolone; Neoplasms, Second Primary; Prednisone; Recurrence; Remission Induction; Time Factors; Vidarabine; Vincristine | 2006 |
Results of CHOP chemotherapy for diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2006 |
Dose-adjusted EPOCH plus rituximab is an effective regimen in patients with poor-prognostic untreated diffuse large B-cell lymphoma: results from a prospective observational study.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Prospective Studies; Rituximab; Survival Rate; Vincristine | 2007 |
Therapy for older patients with diffuse large cell lymphoma: targeting the treatment to the patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Spontaneous pregnancy and normal delivery after repeated autologous bone marrow transplantation and GnRH agonist treatment.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic | 2007 |
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vincristine | 2007 |
Primary renal lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Urea Nitrogen; Creatine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Kidney; Kidney Neoplasms; Lymphoma, Large B-Cell, Diffuse; Prednisone; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 2007 |
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italian
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Rituximab; Transplantation, Autologous; Treatment Outcome | 2007 |
[MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Hydrocortisone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Piperazines; Salvage Therapy; Survival Rate; Thrombocytopenia; Vincristine | 2007 |
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cytarabine; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2007 |
Treatment of AIDS-associated anaplastic large-cell lymphoma with dose-adjusted EPOCH chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Vincristine | 2007 |
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; BH3 Interacting Domain Death Agonist Protein; Biphenyl Compounds; Blotting, Western; Doxorubicin; Etoposide; Humans; Immunoblotting; Immunoprecipitation; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Membrane Proteins; Nitrophenols; Piperazines; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tumor Cells, Cultured; Vincristine | 2007 |
Drug-induced Myc-mediated apoptosis of cancer cells is inhibited by stress protein Hsp70.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Camptothecin; Caspases; Cytochromes c; Enzyme Activation; Enzyme Inhibitors; Estrogens; Etoposide; Gene Expression Regulation, Neoplastic; HSP70 Heat-Shock Proteins; Humans; Lymphoma, Large B-Cell, Diffuse; Oncogene Proteins, Fusion; Proto-Oncogene Proteins c-myc; Translocation, Genetic; U937 Cells; Up-Regulation | 2007 |
Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells.
Topics: Aniline Compounds; Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Caspase 3; Caspase 7; Caspase 9; Drug Resistance, Neoplasm; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Palatine Tonsil; Phenylurea Compounds; Tumor Cells, Cultured; X-Linked Inhibitor of Apoptosis Protein | 2008 |
Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphoma.
Topics: Aniline Compounds; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Caspase 9; Caspase Inhibitors; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Gene Expression; Humans; Lymphoma, Large B-Cell, Diffuse; Phenylurea Compounds; X-Linked Inhibitor of Apoptosis Protein | 2007 |
Could 99mTc-glucarate be used to evaluate tumour necrosis? In vitro and in vivo studies in leukaemic tumour cell line U937.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Etoposide; Glucaric Acid; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Mice, Nude; Necrosis; Neoplasm Transplantation; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Transplantation, Heterologous; U937 Cells | 2008 |
Cutaneous plasmablastic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; HIV Infections; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Skin Neoplasms; Vincristine | 2008 |
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Disease Progression; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Italy; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rituximab; Survival Rate; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2008 |
Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Radiography, Abdominal; Remission, Spontaneous; Time Factors; Vincristine | 1983 |
The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Leucovorin; Lomustine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melphalan; Methotrexate; Middle Aged; Phosphoramide Mustards; Prednisolone; Prednisone; Prognosis; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome; Vincristine | 1994 |
Myelin basic protein in the cerebrospinal fluid of patients with brain tumors.
Topics: Adult; Aged; Astrocytoma; Biomarkers, Tumor; Brain Damage, Chronic; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Follow-Up Studies; Glioblastoma; Humans; Infusions, Intra-Arterial; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Myelin Basic Protein; Treatment Outcome | 1994 |
The management of primary mediastinal B-cell lymphoma with sclerosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Prednisone; Sclerosis; Vincristine | 1994 |
Pseudoleukemia after granulocyte colony-stimulating factor therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myelomonocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasms, Second Primary; Neutropenia; Prednisone; Vincristine | 1995 |
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Interleukin-10; Life Tables; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Neoplasm Proteins; Prognosis; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine | 1995 |
Rapid development of disseminated superficial porokeratosis after transplant induction therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Disease Susceptibility; Doxorubicin; Etoposide; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Porokeratosis; Prednisone; Skin; Vincristine; Whole-Body Irradiation | 1995 |
Treatment of poor prognosis non-Hodgkin's lymphoma with intensive, inpatient combination chemotherapy of brief duration: long-term followup.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Prognosis; Survival Analysis; Vincristine | 1993 |
Alternating chemotherapy of CHOP-Bleo and POEM-Bleo for diffuse large-cell lymphoma: a single-institutional study with a long-term follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Remission Induction; Vincristine | 1993 |
Bilateral hard palate masses.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neurofibroma; Palatal Neoplasms; Prednisone; Vincristine | 1993 |
Pregnancy after autologous bone marrow transplantation for malignant lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infant, Newborn; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Melphalan; Podophyllotoxin; Prednisone; Pregnancy; Pregnancy Outcome; Procarbazine; Remission Induction; Salvage Therapy; Vincristine | 1994 |
Pentostatin increases the acute toxicity of high dose cyclophosphamide.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Synergism; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Pentostatin; Prednisone; Rats; Rats, Inbred Lew; Salvage Therapy; Shock, Cardiogenic; Ventricular Fibrillation; Vidarabine; Vincristine | 1993 |
[Chronic daily oral low-dose etoposide therapy for an aged patient with aggressive lymphoma: a successful case report].
Topics: Administration, Oral; Aged; Etoposide; Female; HTLV-I Antibodies; Humans; Lymphoma, Large B-Cell, Diffuse; Remission Induction; Superior Vena Cava Syndrome | 1993 |
Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors.
Topics: Cell Cycle; Demecolcine; DNA; Enzyme Inhibitors; Etoposide; G1 Phase; G2 Phase; HeLa Cells; Humans; Hydroxyurea; Leukemia, Erythroblastic, Acute; Lymphoma, Large B-Cell, Diffuse; Mitosis; Nocodazole; Receptors, Tumor Necrosis Factor; S Phase; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vinblastine | 1995 |
Reversible renal impairment during leukocytosis induced by G-CSF in non-Hodgkin's lymphoma.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Intestinal Neoplasms; Kidney Diseases; Leukocytosis; Lymphoma, Large B-Cell, Diffuse; Male; Neutropenia; Prednisolone; Recombinant Proteins; Remission Induction; Vinca Alkaloids | 1996 |
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Scapula; Spinal Neoplasms; Vincristine | 1996 |
[Spinal cord compression as the presenting form of non-Hodgkin's lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epidural Space; Etoposide; Female; Humans; Laminectomy; Leucovorin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Methotrexate; Middle Aged; Paresis; Paresthesia; Prednisone; Procarbazine; Soft Tissue Neoplasms; Spinal Cord Compression; Spinal Neoplasms; Thoracic Neoplasms; Thoracic Vertebrae; Urinary Retention; Vincristine | 1995 |
Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Duodenal Neoplasms; Etoposide; Humans; Immunocompromised Host; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Neoplasms, Second Primary; Pancytopenia; Remission Induction; Salvage Therapy; Thigh; Transplantation Conditioning; Vincristine | 1996 |
Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Leukapheresis; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Pilot Projects; Prednisone; Risk; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine | 1997 |
[Combination chemotherapy with BH-AC, mitoxantrone, etoposide, and prednisolone to refractory or relapsed malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Middle Aged; Mitoxantrone; Prednisolone | 1997 |
Modulation of heat-shock protein 70 (HSP70) gene expression by sodium butyrate in U-937 promonocytic cells: relationships with differentiation and apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bucladesine; Butyrates; Butyric Acid; Cadmium Chloride; Carcinogens; Cell Differentiation; Colforsin; Cyclic AMP; Etoposide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Histamine Antagonists; HSP70 Heat-Shock Proteins; Humans; Lymphoma, Large B-Cell, Diffuse; Phosphodiesterase Inhibitors; Stress, Physiological; Theophylline; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1997 |
BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Survival Rate; Treatment Outcome; Vincristine | 1997 |
Advanced diffuse large-cell lymphoma treated with 12-week combination chemotherapy: natural history of relapse after initial complete response and prognostic variables defining outcome after relapse.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Recurrence; Retrospective Studies; Vincristine | 1997 |
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 1998 |
[Interstitial pneumonia in patients treated with VACOP-B therapy for malignant lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Diseases, Interstitial; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1998 |
Two cases of fatal bleomycin pneumonitis complicating the treatment of non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Pneumonia; Prednisolone; Pulmonary Fibrosis; Vascular Neoplasms; Vincristine | 1998 |
p53 gene mutation in the bone-marrow of a patient with diffuse mixed cell type lymphoma at diagnosis predicting eventual progression to large cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Dexamethasone; Disease Progression; Etoposide; Fatal Outcome; Genes, p53; Genetic Markers; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mutation; Sequence Analysis, DNA | 1998 |
Secondary acute myeloid leukemia following treatment with VP16-containing regimens for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Enzyme Inhibitors; Etoposide; Fatal Outcome; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukemia, Monocytic, Acute; Leukemia, Myelomonocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell; Male; Methotrexate; Mitoxantrone; Neoplasm Proteins; Neoplasms, Second Primary; Prednisone; Topoisomerase II Inhibitors; Vincristine | 1998 |
Pulmonary multinodular relapse of non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytarabine; Diagnosis, Differential; Etoposide; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Lung Diseases; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Radiography; Recurrence; Remission Induction; Tuberculosis, Pulmonary | 1998 |
[Intraarterial chemotherapy using a combination of etoposide and cisplatin for recurrent malignant lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cisplatin; Etoposide; Female; Humans; Infusions, Intra-Arterial; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging | 1998 |
A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prospective Studies; Risk Factors; Vincristine | 1999 |
[Lymphoma of the mandible: presentation of 2 cases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Mandibular Neoplasms; Methotrexate; Middle Aged; Prednisone; Remission Induction; Transplantation, Autologous | 1999 |
Diffuse large-cell lymphoma of the testis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Recurrence; Retrospective Studies; Salvage Therapy; Testicular Neoplasms; Treatment Outcome; Vincristine | 1999 |
Diffuse bone increase uptake of gallium-67 related to cyclophosphamide and recombinant human granulocyte-colony stimulating factor (rHuG-CSF) administration.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Gallium Radioisotopes; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Radionuclide Imaging; Recombinant Proteins; Tissue Distribution | 2000 |
Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Immunohistochemistry; Lomustine; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Prednimustine; Prednisone; Regression Analysis; Survival Analysis; Treatment Outcome; Vault Ribonucleoprotein Particles; Vincristine | 2000 |
Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Blotting, Southern; Brain Neoplasms; Cell Division; Cell Transformation, Viral; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Herpesvirus 4, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; In Situ Hybridization; Interferon-gamma; Interleukin-10; Karyotyping; Lymphocyte Activation; Lymphoma, Large B-Cell, Diffuse; Male; Polymerase Chain Reaction; Prednisolone; Receptors, Interleukin-2; T-Lymphocytes; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Vincristine | 2000 |
Long-term administration of oral low-dose topoisomerase II inhibitors, MST-16 and VP-16, for refractory or relapsed non-Hodgkin's lymphoma.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Piperazines; Recurrence; Topoisomerase II Inhibitors | 2000 |
[Is it useful to perform a (67)gallium scintigraphy in the follow-up of patients with gastric lymphoma?].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Fatal Outcome; Follow-Up Studies; Gallium Radioisotopes; Gastrectomy; Gastroscopy; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Methylprednisolone; Mitoxantrone; Neoplasm Recurrence, Local; Paclitaxel; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Stomach Neoplasms; Stomach Ulcer; Tomography, X-Ray Computed; Vincristine | 2001 |
Topoisomerase II inhibitor induced leukemia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors | 2001 |
Autologous peripheral blood progenitor cell transplantation for transformed diffuse large-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cell Transformation, Neoplastic; Cyclophosphamide; Disease-Free Survival; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Retrospective Studies; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2000 |
Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunologic Factors; Immunotherapy; Interferon-alpha; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Vincristine | 2001 |
Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy.
Topics: Acidosis, Lactic; Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colonic Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Humans; Lactates; Liver; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasms, Second Primary; Prednisone; Sodium Bicarbonate; Vincristine | 2002 |
Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Chromosomes, Human, Pair 3; Cyclophosphamide; Cytarabine; Disease-Free Survival; DNA Mutational Analysis; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Etoposide; Female; Genes, bcl-2; Humans; Life Tables; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Point Mutation; Prednisolone; Prednisone; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogenes; Transcription Factors; Treatment Outcome; Vincristine | 2002 |
Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Piperazines; Prednisolone; Remission Induction; Tretinoin; Vincristine | 2002 |
Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung Diseases; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Prednisolone; Prednisone; Rituximab; Sarcoidosis; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 2002 |
Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Middle Aged; Prednisone; Prognosis; Risk Factors; Sclerosis; Thorax; Transplantation, Autologous; Vincristine | 2002 |
Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
Topics: Acyclovir; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Central Nervous System Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Epstein-Barr Virus Infections; Etoposide; Eye Enucleation; Eye Neoplasms; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methylprednisolone; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Optic Nerve Neoplasms; Radiotherapy, Adjuvant; Retinoblastoma; Rituximab; Thiotepa; Vincristine | 2002 |
Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV.
Topics: Adult; Antineoplastic Agents; Azirines; Bleomycin; Cyclophosphamide; Daunorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Procarbazine; Teniposide; Triethylenemelamine; Vinblastine; Vincristine | 1975 |
[A case of diffuse large cell lymphoma treated with combination chemotherapy of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) and BEMP (bleomycin, etoposide, mitoxantrone, procarbazine) with complete remission].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Male; Mitoxantrone; Prednisone; Procarbazine; Remission Induction; Vincristine | 1992 |
Effect of combination chemotherapy with cefoperazone on non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cefoperazone; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Vincristine | 1992 |
[Salvage therapy for recurrent or refractory non-Hodgkin's lymphoma with etoposide, methotrexate, vindesine and prednisolone (EMVP)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Rate; Vindesine | 1992 |
Oral etoposide in the treatment of cutaneous large-cell lymphomas. A preliminary report of four cases.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Skin; Skin Neoplasms | 1992 |
Bilateral primary non-Hodgkin's lymphoma of the adrenal glands with adrenal insufficiency: a case report.
Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisolone; Remission Induction; Vincristine | 1992 |
Salvage therapy for diffuse large-cell lymphoma.
Topics: Bleomycin; Cyclophosphamide; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Procarbazine | 1990 |
Angiotropic (intravascular) large cell lymphoma. A clinicopathologic study of seven cases with unique clinical presentations.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine | 1990 |
MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Mechlorethamine; Methotrexate; Middle Aged; Mouth Mucosa; Prednisone; Procarbazine; Prognosis; Remission Induction; Stomatitis; Survival Rate; Vinblastine; Vincristine | 1991 |
Applications of gallium-67 scintigraphy in the management of patients with malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Citrates; Citric Acid; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Gallium Radioisotopes; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prednisone; Radionuclide Imaging; Vincristine | 1991 |
Childhood Ki-1 lymphoma: presentation as a buttock mass.
Topics: Aneuploidy; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Buttocks; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Gene Rearrangement, T-Lymphocyte; Humans; Ki-1 Antigen; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Remission Induction; Soft Tissue Neoplasms; T-Lymphocytes, Helper-Inducer; Vincristine | 1991 |
[Pharmacokinetic study of etoposide in aged patient with non Hodgkin lymphoma receiving hemodialysis].
Topics: Aged; Drug Administration Schedule; Etoposide; Half-Life; Humans; Infusions, Intravenous; Kidney Diseases; Lymphoma, Large B-Cell, Diffuse; Metabolic Clearance Rate; Renal Dialysis | 1991 |
Granulocytic sarcoma or large cell lymphoma?
Topics: Biopsy; Child, Preschool; Cyclophosphamide; Daunorubicin; Diagnosis, Differential; Etoposide; Female; Humans; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Thiotepa; Vincristine | 1991 |
Increase in topoisomerase-II-mediated DNA breaks and cytotoxicity of VP16 in human U937 lymphoma cells pretreated with low doses of methotrexate.
Topics: Blotting, Western; Cell Line; DNA; DNA Damage; DNA, Neoplasm; DNA, Single-Stranded; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Electrophoresis, Polyacrylamide Gel; Etoposide; Flow Cytometry; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Time Factors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1990 |
ECAPP chemotherapy for lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Procarbazine; Vincristine | 1990 |
Gall bladder perforation in response to chemotherapy in a patient with a histiocytic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ascites; Bile; Bleomycin; Chylous Ascites; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Gallbladder Diseases; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Prednisone; Vincristine | 1988 |
Cutaneous pathology following etoposide therapy.
Topics: Adult; Aged; Biopsy; Carcinoma, Small Cell; Drug Eruptions; Etoposide; Female; Humans; Leukemia, Lymphoid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged | 1987 |